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Abstract
The bovine perfused eye model has been validated as an 
inexpensive and convenient method for the assessment of the 
ability of drugs to lower intraocular pressure (IOP), free 
from the complicating effects of the cardiovascular system, 
the nervous system (including the CNS) and the presence of 
circulating hormones. This preparation also facilitates the 
comparison of drug effects on pressure with effects on the 
uveal vasculature, as well as rapid access to living tissue 
for biochemical analysis. Using this preparation, the 
ocular hypotensive effects of several 3-adrenoceptor 
antagonists have been demonstrated. The pressure lowering 
effect of the 3-adrenoceptor antagonists probably does not 
involve a classical 3-adrenoceptor or ciliary cyclic AMP as 
a signal transduction pathway, and is not dependent upon
intact adrenergic innervation. The presence of a ciliary 
32_adrenoceptor population positively coupled via Gs protein
to a membrane Ca2+ channel is postulated.
Atrial natriuretic factor (Atriopeptin - AP) and the 
nitrovasodilators sodium nitroprusside (SNP) and sodium 
azide, all of which are known to activate guanylate cyclase, 
also reduce IOP. Further, certain L-type Ca^+ channel 
antagonists and the K+ channel agonist pinacidil reduce IOP 
in this preparation. A comparative investigation of the 
pressure lowering and vascular effects of certain of these 
drugs has been undertaken. It is concluded that the
(XV)
pressure lowering effect of these drugs cannot be an outcome 
of their vascular effects, but rather probably results from 
a direct effect on the ciliary epithelial cells.
The bovine perfused eye may be the first isolated organ 
to be subjected to analysis of drug induced changes in 
regional blood flow using a labelled microsphere technique. 
The effects of these drugs on the uveal vasculature are 
varied and complex. Timolol at maximal ocular hypotensive 
dose was found to significantly reduce perfusion in the 
choroid, whereas at supramaximal dose it was found to 
significantly reduce perfusion in the iris. By contrast, a 
maximal ocular hypotensive dose of carteolol significantly 
reduced perfusion in the iris, ciliary body and choroid. 
Doses of SNP or verapamil which are known to reduce IOP in 
this preparation were found to significantly increase 
perfusion in the iris, ciliary body and choroid.
Doses of AP or of sodium azide which are capable of 
producing submaximal decreases in IOP in the bovine perfused 
eye have been shown to produce a significant increase in 
ciliary cyclic GMP. It is concluded that ciliary cyclic GMP 
or Ca^+ may be involved in the control of IOP.
INTRODUCTION
1The Anatomy of The Eve
The Anterior Eye and Retina
The globe of the eyeball consists essentially of three 
layers - the outermost coat, or cornea and sclera, the 
middle layer, consisting of the choroid, ciliary body and 
iris, and the innermost layer, the retina (Fig.l). The 
choroid is the vascular layer, through which arteries run to 
the anterior eye and in which is located a network of small 
vessels which supply part of the requirements of the retina. 
The choroid is separated from the retina by two membranes, 
termed the membrane of Bruch, and the pigment epithelium. 
Arteries of the choroid (Fig.2) continue into the ciliary 
body, and further extensions of these vessels project into 
the iris. The ciliary body (Fig.3) consists of a smooth 
muscle ring (comprising both circular and tangential 
fibres), and functions to enable the lens to focus incident 
light rays onto the retina. It achieves this by stretching 
the lens, causing it to become flatter and decreasing its 
refractive properties, or by releasing tension upon it and 
allowing it to return naturally to its more convex form, by 
way of its inherent elasticity. The iris functions as a 
diaphragm, controlling the amount of light which enters the 
eye and it consists of circular and radial smooth muscle 
fibres. The retina comprises all of the nervous tissue 
responsible for the reception of light and its transmission
2Vitreous
Choroid-
Retina-
nerve
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A n terio r chamber
Conjunctiva
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Fig.l Horizontal section of the eye. Superior Aspect 
(Gray's Anatomy).
Fig. 2 The choroid and iris. (Cray's Anatomy. Masterclass 
edition).
3Fig . 3
C ilia ry  process 
(pars p licata  
ciliaris)
Lens (posterior 
aspect)
Retina
Choroid
Sclera
The interior aspect of the anterior half of the
eyeball, shoving the lens, ciliary body,
corona ciliaris and ora serrata. (Gray's Anatomy).
4to the brain by way of the optic nerve; this nervous tissue 
being an extension of the central nervous system (CNS). The 
retina has its own blood supply, arising as a separate 
arterial branch from the ophthalmic artery. The retina 
terminates at the ciliary body, forming the ora serrata, 
however a forward extension of the retina forms a double­
layered epithelium which covers the ciliary body, termed the 
ciliary epithelium. Internally, the eye has two spaces 
(Fig.l), the larger forming the space between the lens and 
retina, termed the vitreous, and the smaller, between the 
internal surface of the cornea and lens, the aqueous 
chamber. The aqueous chamber is itself divided into the 
posterior chamber (between the posterior surface of the iris 
and the anterior surface of the lens), and the anterior 
chamber (between the anterior surface of the iris and the 
internal surface of the cornea). The vitreous is filled 
with a large mass of hydrated connective tissue, the 
vitreous body or humour, which is bounded by the hyaloid 
membrane. Forward extensions of the hyaloid membrane form 
the suspensory ligaments supporting the lens, known as the 
zonule. The outer edge of the zonule attaches to seventy 
processes extending from the ciliary body; the ciliary 
processes. Viewed posteriorly, these processes appear as 
radial ridges to which the name corona ciliaris 
has been given (Fig.3). The posterior and anterior 
chambers are filled with the aqueous humour, secreted from 
the region of the ciliary epithelium covering the ciliary
5processes, on that part of the ciliary body known as the 
pars plicata.
The blood vessels of the choroid supply many of the 
internal structures of the eye. The choroid, ciliary body 
and iris are supplied by the ciliary system of arteries, 
comprising the medial and lateral long posterior ciliary 
arteries, the short ciliary arteries and the anterior 
ciliary arteries (Figs.4 & 6 ). These ciliary blood vessels 
are often referred to as the uveal vessels. They arise from 
the main arterial supply to the eye, the ophthalmic artery, 
which is itself derived from a branch of the internal 
carotid artery, in the human. Venous blood from the uvea 
(Figs.4 & 7) drains into the episcleral veins, fine veins 
running through the sclera, and from there into the four 
vortex veins, finally leaving the eye by way of the superior 
and inferior ophthalmic veins. The nervous components of 
the retina are supplied from the central retinal artery, a 
branch of the ophthalmic artery arising proximal to the 
ciliary arteries (Figs.4 & 5). The venous blood from the 
retina drains into the retinal veins and hence into the 
ophthalmic veins.
The cornea and the lens are nourished by a process of 
diffusion from the vitreous and aqueous humours of dissolved 
oxygen and nutrients, derived from the various capillaries. 
Additionally, the central cornea absorbs oxygen directly 
from the atmosphere by a process of diffusion.
Fig. 4 The vascular arrangements of the uveal tract.
The long posterior ciliary arteries, one of 
vhich is visible (A), branch at the ora serrate 
(bb) and supply the capillaries of the anterior 
part of the choroid. Short posterior ciliary 
arteries (CC) divide rapidly to form the posterior 
part of the choriocapillaris. Anterior ciliary 
arteries (DD) send recurrent branches to the 
choriocapillaris (ee) and anterior rami to the 
major arterial circle (ff). Branches from the 
circle extend into the iris (g) and to the limbus. 
Branches of the short posterior ciliary arteries (CC) 
form an anastomotic circle (h)(of Zinn) around the 
optic disk, and branches from this (i) join an 
arterial network on the optic nerve. The vortex 
veins (J) are formed by the junctions (k) of the 
suprachoroidal tributaries. Smaller tributaries are 
also shown (m,n). The veins draining the canal of 
Schlemm (o) join anterior ciliary veins and vortex 
tributaries. (From Gray ',5 Anatony . 35th Edition) .
Fig.5 Anterior viev of the retina, shoving the central
retinal artery. Anterior section of globe removed. 
(Gray '.a Anatomy, Masterclass edition) .
Anterior c ilia ry  a rtery
Short c ilia ry  arlerict
A n terio r c ilia ry  a rte ri/
Fig. 6 The arteries of the choroid and iris. Sclera has 
been mostly removed. (Gray's Anatomy. Masterclass 
edition).
8Fig.7 The veins of the choroid. Sclera has been mostly 
removed. (Gray'5 Anatomy. Masterclass edition).
Fig. 8 The extraocular muscles of the human right eye. 
A; lateral rectus, B; superior rectus,
C; medial rectus, D; inferior rectus,
E; superior oblique, acting via the trochlea, a; 
G; inferior oblique. (Bell, 1823).
9The anterior portion of the sclera and the cornea are 
covered by epithelia. The conjunctival epithelium continues 
forward on to the inner surface of the eyelids, thus 
creating the conjunctival sac. The remainder of the sclera 
is enveloped by Tenon's capsule.
Extra-Ocular Muscle
The six extra-ocular muscles (Fig.8), comprising two 
pairs of rectus muscles; superior and inferior, and medial 
(internal) and lateral (external), respectively; and the 
superior and inferior oblique muscles, control movement of 
the eye within the orbit, which is essentially rotation 
about a fixed point in space. The six muscles form a cone, 
with the eyeball itself located at the base of the cone, the 
apex of the cone located posteriorly in the orbital cavity. 
The space between the eyeball and the orbit not filled with 
muscle is filled with orbital fat, and the lacrimal gland, 
responsible in part for the production of tear fluid.
10
Nerve Supply
The eye has a rich supply of autonomic nerves, but 
these nerves are distributed only within the uvea and the 
extraocular parts of the retinal blood vessels (Bill & 
Sperber, 1990). Sympathetic nerves originate in the 
superior cervical ganglion, and parasympathetic nerves in 
the pterygopalatine and ciliary ganglia. The precise role 
of the nerves is not very well understood.
With the exception of the visual apparatus, sensory 
impulses are conveyed through the long and short ciliary 
nerves (all part of the autonomic nervous system - Fig.9). 
The long ciliary nerves are composed mainly of axons of 
nerve cells in the Gasserian ganglion - the ganglion of the 
trigeminal nerve. These nerves convey impulses from the 
iris, ciliary body and cornea. The short ciliary nerves 
also contain axons of the trigeminal; they pass through the 
ciliary ganglion into the naso-ciliary nerve. These fibres 
carry impulses from all parts of the eyeball, but 
principally from the cornea. Preganglionic parasympathetic 
motor fibres to the ciliary muscle and iris run through the 
lower division of the oculomotor as the motor root of the 
ciliary ganglion; the postganglionic fibres supplying the 
muscles are contained in the short ciliary nerves.
Sympathetic fibres from the superior cervical ganglion 
enter the orbit as the sympathetic root of the ciliary 
ganglion and run into the short ciliary nerves to supply the
11
NASO-CILIARY nerve V
GASSERIAN
GANGLION
N.V
M p Ar
>v \C>
CILIARY GANGLION
SHORT CILIARY NERVES
Fig.9 Nervous supply to the eyeball. (Davson, Phvsinlnov
nf the F v p 'I
CORNEA
Fig.10 Cross-section through the anterior segment of the 
eye illustrating the chamber angle. Under steady- 
state conditions intraocular pressure is maintained 
by a balance between the formation of aqueous humour 
by active secretion by the ciliary processes (A), 
and its drainage by outflow pathways, in particular 
the trabecular meshwork (B) and Schlemm's canal (0), 
into aqueous veins (D). (Karnezis & Murphy, 1988)
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vessels of the globe and the dilator pupillae fibres of the 
iris. Other sympathetic fibres avoid the ciliary ganglion, 
passing through the Gasserian ganglion and entering the 
globe in the long ciliary nerves, whilst still others enter 
the globe in the tunica adventitia of the ciliary arteries.
The Aqueous Humour and Intraocular Pressure
The aqueous humour is a transparent colourless fluid, 
formed continuously in the posterior chamber by the ciliary 
processes (Fig.10). It passes through the pupil into the 
anterior chamber, from where it is drained into the venous 
system in the angle of the anterior chamber by way of 
Schlemm's canal, in the primate eye. Nonprimate eyes 
possess a structure equivalent to Schlemm's canal (Fig.11), 
known as the angular aqueous plexus (Tripathi, 1974). As in 
primates, the plexus forms a circumferential structure in 
lower mammals, birds and many reptiles, but is more 
localized in amphibians and fishes. Schlemm's canal is a 
circular canal in the corneo-sclera of the 1imbus (Figs.12 & 
13), which comes into relation with the aqueous humour on 
the one hand and the intrascleral venous plexus on the 
other. It is essentially an endothelium-1ined vessel. On 
the outside it rests on the scleral tissue whilst on the 
inside, nearest the anterior chamber it is covered by a 
meshwork of endothelium covered trabeculae: the trabecular
13
.11 Diagrammatic representation of the angular region 
of a primate (A) and a lover placental mammal (B) 
shoving comparative morphological organizations.
S: sclera; C: cornea; I; iris. AH: angular meshvork 
AP : angular aqueous plexus; CM: ciliary muscle;
CC: ciliary cleft; CF: ciliary processes;
ISC: intrasc'leral collector channels.
(Tripathi, The Eye).
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SCLERA W ITH  
COLLECTOR CHANNEL
SCHLEMM'S CANAL
ENDOTHELIAL MESHWORK
CORNEO-SCLERAL  
MESHWORK
UVEAL MESHWORK
Fig.12. Schematic representation of a section through 
chamber-angle tissue. (Bill, Physiol. Rev.)
Fig.13. Schematic drawing of the chamber-angle in
primates, shoving the three distinct parts of 
the trabecular meshwork. 1. Uveal Meshvork.
2. Oorneo-Scleral Meshvork. 3. Endothelial 
Meshvork. (Rohen, Structure of the Eve).
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meshwork or pectinate ligament. The meshwork has been 
divided histologically into three parts with 
characteristically different ultrastructures; the innermost 
portion is the uveal meshwork, the middle portion is the 
corneoscleral meshwork, and the third portion, lying 
immediately adjacent to the canal is referred to as the 
endothelial meshwork.
Although most of the outflow of aqueous is via the 
trabecular meshwork and Schlemm's canal, or the angular 
aqueous plexus in the nonprimate eye, a small proportion 
(approximately 20%) leaves the anterior chamber via the 
uveoscleral pathway; here the aqueous flows through the 
ciliary body into the suprachoroidal space, to be drained by 
the venous circulation in the ciliary body, choroid and 
sclera.
As a circulating fluid, the aqueous humour is a medium 
whereby the lens and cornea receive their nutrient 
materials. The ciliary epithelium, as previously related 
consists of a double layer of cells. The layer immediately 
adjacent to the aqueous is non-pigmented, whilst the outer 
layer is heavily pigmented and represents the forward 
continuation of the retinal pigment epithelium. The non- 
pigmented layer represents the forward continuation of the 
neuroepithelium from which the retinal cells are derived.
The ciliary epithelial cells have been subjected to 
intensive study histologically, and with the electron 
microscope. A striking feature of the cells is the
16
interdigitatIon of the lateral surfaces of adjacent cells, 
and the basal infoldings (Fig.14), which is a characteristic 
feature of secretory epithelia concerned with fluid 
transport (Bill, 1975). The relation of the two epithelial 
cell layers is of importance, since as the secreted aqueous 
humour is derived from the ultrafiltrate of blood in the 
stroma of the ciliary body, transport must occur across both 
layers. The cells of the two layers face each other apex- 
to-apex, as a result of the invagination of the 
neuroepithelial layer during embryogenesis. Thus the basal 
aspects of the non-pigmented cells face the aqueous humour 
(Fig.15).
IOP is largely determined by the rate of formation of 
aqueous humour, the rate of outflow (by at least two 
routes), and episcleral venous pressure.
The Blood-Aqueous Barrier
A restraint in the free passage of many solutes from 
the blood vessels of the ciliary stroma into the aqueous 
humour exists. This has come to be known as the blood- 
aqueous barrier, the anatomical correlate of which are the 
tight junctions in the non-pigmented layer. The i.v. 
injection of horseradish peroxidase into the monkey has been 
shown to lead to a rapid filling of the ciliary stroma by 
the enzyme (Vegge, 1971). The enzyme passes through the
Fig.14 A section of portions of tvo adjacent ciliary 
epithelial cells of the rabbit shoving complex 
interdigitations of their boundaries (B). 
Zonular fibres (Z) can be seen in close 
approximation to the surface of these cells. 
Endoplasmic reticulum (ER) and mitochondria (M) 
also visible. (After an electron micrograph by 
Pappas & Smelser).
Base ■
yrj.-y/.*: ' -Basement
Membrane
Base-
lit«§§iipi
#} [TL#|V\ V y  ff\\
ULtLIMLLjuIL.
Pigmented
Cells
Apex to Apex 
Junctions
Non-pigmented
Cell
Basement
Membrane
Aqueous Humour
Fig.15 The apex-to-apex relation of the tvo layers of cells 
of the ciliary epithelium. (Davson, Physiology nf 
the Eve).
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many fenestrations present in the blood capillaries of the 
ciliary body, and also has been found to fill the spaces 
between the pigmented cells. However, it is prevented from 
entering the aqueous by the tight junctions of the non- 
pigmented layer, between the cell apices. Comparable 
results have been reported in the mouse (Shiose, 1970) and 
in the rabbit (Uusitalo et a 1 . , 1970).
A similar barrier to the passage of solutes exists in 
the retinal pigment epithelium, thus forming a blood- 
vitreous barrier between the vitreous and the blood 
capillaries of the choroid. Blood capillaries with tight 
junctions in their endothelia form further physiological 
barriers (functionally similar to the blood-brain barrier) 
in the iris and retina.
Secretion and Composition of Aqueous Humour
Aqueous humour is derived from an ultrafiltrate of 
plasma in the ciliary stroma, and as such has a chemical 
composition quite similar to that of plasma. However it 
differs from that of plasma in that it is richer with 
respect to chloride, bicarbonate, lactate, pyruvate, 
ascorbate and total amino acids. The concentration of 
sodium, potassium, calcium and magnesium ions, urea and 
glucose are all lower than in plasma. There are also small 
quantities of all of the plasma proteins present in the
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aqueous, albeit at concentrations less than 1% those of 
plasma. The table below shows the comparitive chemical 
composition of aqueous humour and plasma in the rabbit.
CoiiDonent. Aaueous Humour Plasma
Na + 143 .5 151.5
K+ 5 .25 5.5
Ca2 + 1.7 2.6
Hg2 + 0 .73 1.0
Cl" 109 .5 108 .0
hco3" 33 .6 27 .4
Lactate 7.4 4.3
Pyruvate 0 .66 0 .22
Ascorbate 0 .96 0 .02
Urea 7 .0 9.1
Reducing Value
(as glucose) 6.9 8.3
Total Amino Acids 0.17 0 .12
Table 1. Chemical composition of aqueous humour and blood
plasma of the rabbit. Concentrations expressed in 
mmol/kg of water. (After Davson, 1969).
Because the concentration of electrolytes in the 
secreted aqueous is not equal to that of a simple 
ultrafiltrate of plasma, aqueous humour must be actively 
secreted by the ciliary epithelium into the posterior 
chamber. A consideration of Gibbs-Donnan equilibrium 
demonstrates this. If the aqueous were simply an 
ultrafiltrate of plasma, then in accordance with Gibbs- 
Donnan equilibrium, the concentrations of positive ions such 
as potassium and sodium would be greater in the plasma than
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in the aqueous. The opposite would be the case with the 
respective concentrations negative ions, such as bicarbonate 
and chloride. Further, the actual values of the ratios of 
the concentrations of each respective ion in aqueous to 
plasma would conform to the values obtained experimentally 
when plasma is dialysed against its own filtrate. As Table 
2 indicates, however, this is not the case. Therefore the 
aqueous is actively secreted.
Component Done. in Aqueous Cone. in Dialysate
Cone. in Plasma Cone. in Plasma
Na + 0 9b 0 .945
4- 0.95 5 0 .96
_ 2 + 0 .5 8 0 .65
Mg *■+ 0 .73 0 .30
HCQo" 1.26 1.04
Cl" 1.015 1.04
Urea 0 .37 1.00
Table 2. Values of the tvo distribution ratios. Ratio
of concentration in aqueous to concentration in 
plasma; ratio of concentration in dialysate to 
concentration in plasma. (Davson, Physiology of 
the Ocular and Cerebrospinal Fluids).
Such active secretion by the ciliary processes is 
accomplished by the transport of one or more ions from the 
blood side of the system to the aqueous side. The osmotic 
gradient caused by the transport of the ion or ions leads to 
a flow of water, and, depending upon the permeability
characteristics of the limiting membranes across which the 
transport occurs, the fluid may be ultimately isotonic, 
hypertonic or hypotonic. Thus the process in the eye takes 
place across the ciliary epithelium (Fig.16); in the ciliary 
stroma the blood is filtered by the capillaries to produce 
an ultrafiltrate comparable with tissue fluid in other parts 
of the body. Because of the large fenestrations in the 
ciliary capillary endothelia, this ultrafiltrate still bears 
a considerable amount of protein. The non-pigmented 
epithelium, however, acts as a diffusional barrier to this 
protein and to most of the other constituents of the 
ultrafiltrate, so that the transport is slowed and becomes 
selective. The essential hypothesis of aqueous secretion, 
(Cole. 1977), is that the non-pigmented cells absorb 
selectively sodium ions from the stroma and transport them 
into the intracellular clefts which are closed at the 
stromal side by tight junctions but are open on the aqueous 
humour side. The development of hyperosmolarity in the 
clefts leads to osmotic flow of water from the stroma and 
thus to a continuous flow of water along the clefts. The 
passage of other ions may also be governed by independent 
active processes, for example, chloride, potassium and 
bicarbonate ions. Others may diffuse passively down 
concentration gradients established by the primary process. 
The inhibition of active transport of sodium by the cardiac 
glycosides is related to the inhibition of Na+-K+-Mg2+- 
ATPase present in the membranes of the non-pigmented cells.
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Cole (1977) reported that stropanthin G reduced Influx of 
sodium into the anterior chamber by more than 50%. Bonting 
and Becker (1964) reported that when ouabain was injected 
into the vitreous humour, there was a fall in IOP, due to a 
reduction in the rate of secretion of aqueous. The effects 
of ouabain are strongly suggestive of the existence of a 
primary active transport of sodium ion across the ciliary 
processes. A probable linkage of this with an active 
transport of bicarbonate is suggested by the prominent 
action of acetazolamide. which reportedly lowers IOP and 
reduces the rate of secretion of aqueous by approximately 
50% (Garg & Oppelt, 1970). The drug appears to affect an 
ion-secreting mechanism. As acetazolamide inhibits the 
enzyme carbonic anhydrase, it is probable that its effect 
upon aqueous secretion is mediated by the inhibition of 
synthesis of bicarbonate by the secretory cells.
Passive filtration may contribute to aqueous secretion 
also. Bill and Bdrdny (1966) reported that an artificially- 
induced rise in IOP caused a reduction in secretion. This 
has been confirmed in the monkey (Bill, 1968). An 
intracameral injection of erythrocytes yielded a partial 
blockade of the trabecular meshwork, and hence an elevation 
in IOP. This led to a suppression of aqueous secretion, 
corresponding to 0.06ul/min/mmHg rise in pressure.
Therefore with a normal secretion rate of 1.24/il/min, a rise 
in IOP of approximately 20mmHg should theoretically suppress 
aqueous secretion altogether. This does not in fact occur.
24
however. It is well established that aqueous secretion will 
continue even against very high pressures. But the 
observation does indicate that when IOP reaches a critical 
level, the influx by secretion is just balanced by an 
outflow through the drainage channels.
Glaucoma
The clinical condition of glaucoma is a common disease 
which afflicts people mainly from middle age onwards. 
Approximately two million people in the United States suffer 
from some form of the disease, the numbers in other Western 
countries including the United Kingdom being proportionally 
similar. The boundaries between glaucoma, low tension 
glaucoma and ocular hypertension are indistinct, however 
glaucoma is often associated with an IOP of greater than 
21mmHg. The disease consists of pathological changes in the 
optic disk and axons of the optic nerve, and a chronic loss 
of visual field over a period of years, in most cases. Low 
tension glaucoma is defined as the condition whereby the 
pathological changes associated with glaucoma and loss of 
visual field are present, but with a normal IOP. Ocular 
hypertension is defined as the condition whereby IOP is 
greater than 21mmHg, but there are no pathological changes 
present associated with glaucoma, although this condition 
often heralds the development of glaucoma. Jay (1992)
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suggests that an eye found to be in such a condition should 
be treated as though glaucoma were present. The disease may 
be caused by a number of different factors, such as the 
bowing of the iris over the drainage angle (Narrow Angle 
Glaucoma), thus partially occluding the passage of aqueous 
through the trabecular meshwork into the canal of Schlemm. 
This leads to an elevated IOP which stretches the scleral 
layer, and further leads to cupping of the optic disk. IOP 
may rise as high as diastolic pressure in the retinal 
vessels, thus giving rise to progressive retinal ischaemia 
and detachment, with concomitant increasing loss of visual 
field (scotoma). In such cases topical application of a 
muscarinic agonist such as pilocarpine, instilled in the 
form of eyedrops will reduce IOP via a reduction in outflow 
resistance, both by mediating a miosis (contraction) of the 
iris, and by improved flow through the trabecular meshwork, 
which is brought about by contraction of the ciliary muscle 
and consequent pull on the scleral spur, leading to an 
alteration in the configuration of the meshwork fibres 
(Havener, 1983). When IOP is only moderately elevated such 
drug treatment is often all that is necessary to return it 
to its normal value of 10 to 15mmHg above episcleral venous 
pressure. In more extreme cases however, when drug 
treatment alone fails to control the condition, surgery to 
form an opening in the iris through which the aqueous humour 
may drain (iridectomy) will be performed. This procedure may 
be carried out as a non-invasive technique using an N-YAG
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laser; termed N-YAG laser iridotomy. Chronic open-angle 
glaucoma (COAG) consists of a partial blockage of the 
trabecular meshwork, perhaps by the build-up of cellular 
debris, or by glycosaminoglycan deposits, which decreases 
the rate of outflow of aqueous humour, also leading to an 
elevated IOP. This is the most common form of glaucoma and 
may be treated via the instillation of eye drops containing 
a drug (such as a 3-adrenocept.or antagonist) which will 
reduce the rate of secretion of aqueous from the ciliary 
processes. thus mediating a reduction in IOP. As with 
Narrow Angle Glaucoma, when drug treatment fails to 
adequately control the condition, the disease may be treated 
surgically by trabeculectomy or Scheie's thermosclerostomy, 
or via N-YAG laser trabeculoplasty. In each case, the 
procedure involves the creation of a fistula through which 
the aqueous can flow. In trabeculectomy, the fistula so 
formed is 'guarded' by a superficial scleral flap, wheras in 
Scheie's procedure, the fistula passes through the entire 
thickness of the sclera.
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Drugs Which Lower Intraocular Pressure 
3-Adrenoceptor Antagonists
Since 1967, when Phillips et al. discovered that oral 
propranolol will reduce IOP in patients with ocular 
hypertension, many 3-adrenoceptor antagonists have been 
evaluated clinically for topical ocular hypotensive 
activity, and several members are in current clinical use. 
The effect of this group of drugs upon aqueous humour 
dynamics has been well established, both clinically 
(Zimmerman et a l .. 1977; Keates & Stone, 1984; Sugrue et 
a l .. 1985) and experimentally in several species in vivo 
(Nathanson. 1981; Potter. 1981: Liu et al .. 1983). The (-)- 
isomer of timolol is a potent, non-selective 3-adrenoceptor 
antagonist (Scriabine et al .. 1973), often prescribed in 
cases of COAG to lower IOP. The effect of the drug is known 
to be due to a reduction in the rate of formation of aqueous 
humour. Vareilles et al . (1977) first reported the ability
of topically administered timolol to lower IOP; this group 
demonstrated that the instillation of 0.5% and 1.5% 
solutions of (-)-timolol significantly lowered IOP in 
rabbits with an experimentally-induced form of OAG, 
ut i 1 ising ©c-chymotrypsin. This form of induced OAG is most 
likely a consequence of impaired outflow facility (Sears & 
Sears, 1974). The pathological changes occurring in the©^- 
chymotrypsin pretreated rabbit eye somewhat resemble those
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observed in human glaucoma, those being principally the 
progressive cupping of the optic disk and atrophy of the 
optic nerve head (Best et al., 1975). In contrast to ocular 
hypertensive, c^-chymotrypsin pretreated rabbits, the effect 
of topical timolol on the IOP of normotensive rabbits is 
less well defined. Significant and reproducible falls in 
IOP have been observed in some studies (Radius et al.. 1978; 
Bar-Ilan. 1984; Alkondon et al.. 1986), but not in others 
(Vareilles et a l .. 1977; Bartels et a 1.. 1980; Boas et a l .. 
1981; Watkins et a l .. 1985; Woodward et al.. 1986). The IOP 
in ocular normotensive dogs and cats is lowered by topical 
timolol in a dose-dependent manner (Svec & Strosberg, 1986; 
Colasanti & Trotter, 1981). Seidehamel and Dungan (1974) 
reported that the oral administration of a large volume of 
water (60 to 100 ml/kg) to conscious rabbits elicits a 
marked and rapid rise in IOP. which returned however to its 
baseline value in less than 2h. The effect of this water 
loading upon IOP is due to a reduction in the osmolality of 
the blood (van Loenen et al., 1984) and hence the 
establishment of an osmotic gradient between the aqueous and 
the plasma, leading to increased aqueous secretion. Once 
again, the effect of timolol on this model is contradictory, 
an antagonism of the water load-induced increase in IOP 
being observed by some workers (Vareilles et a 1., 1977; Liu 
et al., 1984), but not others (Rowland & Potter, 1980; 
Palkama et a 1., 1985).
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In contrast to results obtained in ocular normotensive 
rabbits, the instillation of timolol to normal human 
volunteers invariably lowers IOP (Katz et al.. 1976; Coakes 
& Brubaker, 1978; Yablonski et al .. 1978). Topical timolol 
is also very effective in lowering IOP in patients with 
elevated IOP. such as in COAG (Radius et al., 1978;
Zimmerman &. Boger, 1979). Fluorophotometric studies in 
human volunteers indicate that the ocular hypotensive effect 
of timolol is mediated by its ability to reduce the rate of 
secretion of aqueous (Coakes & Brubaker. 1978; Yablonski et_ 
a l ., 1978: Schenker et a l ., 1981; Dailey et al.. 1982). In 
general, topically applied timolol has been observed to have 
little or no effect on the facility of outflow in humans 
(Zimmerman et al.. 1977: Sonntag et a 1.. 1978), although a 
small increase in outflow facility has been reported in some 
patients in response to topical timolol (Thomas & Epstein. 
1981). The ability of timolol to reduce aqueous secretion 
has also been observed in the rabbit (Vareilles & Lotti. 
1981). the cat (Liu & Chiou. 1981) and the monkey (Miichi & 
Nagataki. 1983). The site of action of topically applied 
timolol is believed to be local in humans because the 
reduction in IOP is greater in the treated than in the 
untreated contralateral eye, following unilateral 
administration of the drug (Katz et al.. 1976; Zimmerman & 
Kaufman, 1977). Why timolol should lower IOP in the 
contralateral eye is unknown, however it has been proposed 
that the effect may be due to sufficient timolol entering
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the systemic circulation and thus locally affecting the 
ciliary processes of the contralateral eye. The drug may 
also act at a site either within or via the central nervous 
system (Neufeld et al.. 1983). It has further been 
suggested that timolol may act to reduce aqueous secretion 
by reducing the levels of melatonin in the iris and ciliary 
body (Rhode et al.. 1985). Indeed, orally administered 
melatonin reportedly lowers the IOP of healthy volunteers 
(Samples et a 1.. 1988). However, levels of melatonin in the
iris and ciliary body of rabbits and chicks are unaltered by
topical timolol (Rhode & Chiou, 1987).
The presence of 8-adrenergic receptors in ciliary 
tissue has been demonstrated from results of radioligand 
binding and adenylate cyclase activation studies (Neufeld & 
Page. 1977; Page & Neufeld. 1978: Dafna et al ., 1979;
Nathanson. 1980; Bhargava et a l ., 1980; Bromberg et a l ..
1980; Cepelik & Cernohorsky. 1981). Many of these authors 
have inferred the involvement of 0-adrenergic receptors in 
aqueous humour formation. It appears that these ocular 
receptors are primarily of the 02 subtype (Potter & Rowland.
1978; Nathanson. 1980. 1981; Cepelik & Cernohorsky, 1981; 
Colasanti & Trotter. 1981: Schmitt et al.. 1984). In the 
rabbit eye 0-adrenoceptors are present mainly in the ciliary 
epithelium, but also in the walls of the episcleral vessels 
(Dafna et a 1.. 1979).
Controversy surrounds the nature of the mechanism of 
action of timolol as an ocular hypotensive agent. It is
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tempting to assume that blockade of 3-adrenoceptors In the 
ciliary processes is the basis of action of the drug. 
However, various sources of evidence suggest otherwise 
(Lotti et al., 1984). To date, considerable bodies of 
evidence have been amassed, both to support the hypothesis 
that 3-adrenoceptor antagonists lower IOP via antagonism of 
a classical 3-adrenoceptor, and also to support the 
hypothesis that 3-adrenoceptor antagonists do not lower IOP 
via antagonism of a classical 3-adrenoceptor. Each of these 
hypotheses are considered in the following sections.
Experimental Evidence that 3-Adrenoceptor Antagonists Lower 
IOP via Antagonism of a Classical 3-Adrenoceptor
Numerous studies on the secretion of aqueous humour 
suggest that the process is modulated by ciliary 32
adrenoceptors (reviewed by Potter. 1981: Potter & Rowland, 
1981). The ocular structures associated with aqueous humour 
dynamics are rich in 32 adrenoceptors, and most 3-
adrenoceptor antagonists are known to lower IOP in vivo, 
including a number of structurally unrelated agents having 
3-adrenergic blocking properties. The 3-adrenoceptor 
agonist terbutaline is reported to increase aqueous 
formation in primates (Nilsson et al.. 1990). Timolol is a 
potent 3i and 32 adrenoceptor antagonist, which is not,
however noted for any other pharmacologic activities shared
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by a number of 0-adrenergic antagonists, such as intrinsic
sympathomimetic activity, membrane stabilizing activity or
local anaesthetic activity. However timolol is one of the
most effective and widely studied agents known to affect
aqueous secretion and IOP. Wax and Molinoff (1987)
demonstrated that timolol effectively displaces radioligand 
binding to 02~adrenergic receptor binding sites in membrane
fractions of both iris and ciliary body, obtained from the 
human eye. A similar result was obtained in the rabbit 
(Neufeld & Page, 1977; Schmitt et al.. 1984), and also with 
ciliary processes obtained from rabbit (Bromberg et al .,
1980), sheep (Trope & Clark, 1982) and bovine (Elena et a l .. 
1984) eyes. Comparable activity was observed for inhibition 
of adenylate cyclase in ciliary processes obtained from 
rabbits (Nathanson. 1980, 1985) and humans (Nathanson,
1981), and in non-pigmented epithelial cells of the bovine 
ciliary processes (Elena et a 1.. 1984).
For a compound to be active as a pharmacological 
antagonist, there must be tonic agonist-induced stimulation 
to block. Thus, the ability of timolol to lower IOP implies 
that an endogenous adrenergic tone stimulating 0- 
adrenoceptors exists in the eye. Aqueous humour formation 
in human volunteers is decreased by approximately 45% during 
sleep (Reiss et a 1., 1984), and in contrast to daytime. 0.5% 
timolol is devoid of any ocular hypotensive effect (Topper & 
Brubaker, 1985). These observations suggest that endogenous 
adrenergic activity during the day stimulates aqueous humour
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formation and that this stimulus subsides during sleep. 
Supportive evidence for this comes from experiments in which 
the topical application of isoprenaline failed to alter 
aqueous humour formation in volunteers during the day, but 
significantly increased it during sleep (Larson & Brubaker. 
1988). In contrast to this, however, experiments in rabbits 
have indicated that prolonged sympathetic nerve stimulation 
decreases aqueous humour formation (Belmonte et a 1., 1987).
Nathanson (1981) showed that isoprenaline stimulates 
cyclic AMP synthesis and increases aqueous formation in the 
monkey eye. while timolol blocks these effects. This lends 
support to the classical hypothesis that control of aqueous 
secretion is via a classical 3-adrenoceptor. Linner and 
Prijot (1955) noted that cervical sympathetic ganglionectomy 
resulted in reduced aqueous flow.
Experimental Evidence that 3-Adrenoceptor Antagonists do not 
Lower IOP via Antagonism of a Classical 3-Adrenoceptor
Timolol and other 3-adrenoceptor antagonists inhibit 
the production of intracellular cyclic AMP. However, agents 
such as cholera toxin (Gregory et al.. 1981) and forskolin 
(Caprioli & Sears. 1983; Smith et a 1.. 1984; Bartels et a 1.. 
1987: Shibata et al.. 1988) stimulate the production of 
intracellular cyclic AMP, yet they also lower IOP by 
reducing the rate of formation of aqueous. Aqueous outflow
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facility remains unaltered (Caprioli et a 1.. 1984; Leeet
al.. 1984). Topically applied timolol can block 3-
adrenoceptors in the eye as evidenced by the attenuation of
the ability of topical isoprenaline to blunt both the
increase in the IOP of rabbits following water loading, and
the enhancement of levels of cyclic AMP in rabbit aqueous
humour by this 3-adrenergic agonist fVareilles et al.. 1977;
Schmitt et a 1.. 1981b). The doses of timolol required to
block both responses to isoprenaline are much less than
those required for ocular hypotensive activity, thus
implying that no relationship exists between the two
phenomena. Additionally, the effectiveness of various 3-
adrenoceptor antagonists in lowering IOP in rabbit models of
experimental ocular hypertension reportedly does not
correlate with their ability to block 3-adrenoceptors
(Bonomi et a 1.. 1979) . However, in this study the criterion
used for 3-adrenoceptor antagonism was isoprenaline-induced 
tachycardia. This is a 3_l mediated response and
experimental evidence indicates that mainly 32 receptors
exist in the ciliary processes (Cavero et a l .. 1983). A 
lack of correlation between 32 adrenoceptor antagonism and
ocular hypotensive activity is emphasised by comparing
timolol with the 3-adrenoceptor antagonist betaxolol. The 
drug exhibits an in vitro pA2 value for guinea-pig cardiac
3i~adrenoceptors of 8.5 to 8.8. but an in vitro pA2 value
for guinea-pig tracheal 32~adrenoceptors of only 5.4 to 7.0
(Schmitt et a l .. 1984: Manoury et al.. 1987). Thus
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betaxolol is a highly 0^ selective antagonist, exhibiting 
approx. a 850:1 ratio of binding of to 02 adrenoceptors, 
at extraocular sites. The ocular response in humans to both 
drugs however is not markedly different (Levy et al.. 1985; 
Stewart et a 1.. 1986). More recent studies, however suggest 
that the ocular hypotensive effect of betaxolol is less than 
that of timolol (Allen et al.. 1986; Allen & Epstein, 1986), 
but both drugs are in common clinical use as potent ocular 
hypotensive agents. The elevated intraocular pressure of 
glaucoma patients is lowered by the twice-daily instillation 
of 0.125% (Radius, 1983) and 0.25% (Levy & Boone, 1983; 
Caldwell et a l .. 1984) betaxolol.
The 0-adrenoceptor antagonist sotalol reportedly 
inhibits the production of intracellular cyclic AMP, as do 
timolol and the other 0-adrenoceptor antagonists. Sotalol, 
however, when applied topically at 2% concentration to 
patients with COAG has no effect upon IOP (Mertd Sc Stryz.
1983). This suggests that the observed effect of timolol 
upon IOP may be independent of levels of ciliary cyclic AMP.
The fact that topically applied (+)-timolol can lower 
IOP of both rabbits (Share et al.. 1984) and humans (Keates 
Sc Stone, 1984: Mills et al . . 1988) has also been used to 
support the contention that the ocular hypotensive effect of 
timolol is not mediated via a 0-adrenoceptor (Liu Sc Chiou. 
1981; Chiou et al .. 1985). Both timolol and its (+)- 
enantiomer were found to be equally active in reducing 
aqueous humour production when perfused intracamera 1ly in
the anaesthetised cat. However, only one concentration 
(0.005%) of each agent was employed (Liu & Chiou, 1981).
Both enantiomers were also found to be equipotent after 
topical administration in a model which indirectly measures 
aqueous humour secretion in conscious rabbits (Chiou. 1983). 
The ability of topically applied (+)-timolol to lower the 
elevated IOP inoC-chymotrypsin- pretreated rabbits is 
approximately one-third that of timolol (Share et a 1.,
1984). Additionally, the instillation of solutions of (+)- 
timolol ranging from 0.25% to 2% has been found to lower IOP 
in glaucoma patients, however all of the concentrations of 
(+)-timolol were less effective than 0.25% (-)-timolol 
(Mills et a 1.. 1988). ( + )-timolol at 1% concentration has
some extraocular 0-adrenoceptor blocking acivity in human 
volunteers, although it is reportedly 13 times less potent 
than (-)-timolol at human bronchial 02~adrenoceptors. and
additionally is 49 times less potent than (-)-timolol at 
extraocular 02~adrenoceptors in animal studies (Richards &
Tattersf ieId, 1985.: 1987) . This observation is further 
supported by the finding that (+)-timolol has only 3% of the 
potency of (-)-timolol in blocking the isoprenaline-induced 
synthesis of cyclic AMP in ICB preparations (Liu et al..
1981; 1983). ( + )-t.imolol is about one-third as potent as
timolol in displacing ^H-dihydroalprenolol binding to iris- 
ciliary body tissue, reducing aqueous formation and lowering 
IOP ofc^-chymotrypsin hypertensive eyes (Share et a 1..
1984). The (+)-enantiomer is fifty to ninety times less
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potent than the (-)-enantiomer in antagonising the effects 
of isoprenaline on pulmonary and atrial 3-adrenergic 
receptors (Share et a 1., 1984), and may be effective in 
lowering IOP at concentrations which may reduce the systemic 
side effects associated with peripheral 3-adrenergic 
blockade. The inhibitory effect of both enantiomers of 
timolol upon isoprenaline-induced stimulation of adenylate 
cyclase in the rabbit ciliary processes is comparable 
(Nathanson, 1988). In water-loaded pigmented rabbits both 
enantiomers blunt the peak increase in intraocular pressure, 
the (-)-enantiomer is only slightly more effective (Liu et 
aT. . 1983) .
Third neurone Horner's syndrome can occur spontaneously 
in humans or secondary to an underlying disorder, for 
example, migrainous neuralgia, or a tumour (such as a 
lymphoma), and is the clinical equivalent of superior 
cervical ganglionectomy. Aqueous humour secretion in such 
patients is normal however. The suppression of aqueous 
secretion following 0.5% timolol is the same in such 
individuals as in the normal population (Wentworth & 
Brubaker, 1981). This suggests a postsynaptic locus of 
action of timolol and the lack of a need for intact 
adrenergic innervation. However, the results of this study 
contrast with preclinical findings. The ability of 4% 
timolol to lower the IOP of cats is completely prevented by 
superior cervical ganglionectomy (Colasanti & Trotter, 
1981.1983). This observation implies that an intact
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adrenergic innervation is essential for the ocular 
hypotensive action of the drug. Adrenergic innervation is 
also required for timolol to block the increase in IOP 
following the water-loading of ocular normotensive rabbits, 
as indicated by the lack of effect in denervated eyes (Liu 
et al.. 1984). Thus a paradox exists between the clinical 
and preclinical findings.
Treatment of the eye with various (3-adrenoceptor 
agonists will also lower IOP. although the literature is 
much confused in this area of study. There exists fairly 
widespread agreement that topical administration of 
adrenaline to the human eye leads to a decrease in IOP. and 
indeed the IOP lowering effects of adrenaline and timolol 
are additive in the human. However, the mechanism of the 
lowering of IOP with adrenaline appears to be different to 
that associated with the 3-adrenoceptor antagonists.
Topical administration of adrenaline leads to an increase in 
aqueous humour production with a concomitant initial rise in 
IOP (Townsend & Brubaker. 1980; Schenker et a l .. 1981). 
followed within thirty minutes by an increased facility of 
outflow (Sonntag et al.. 1979; Townsend & Brubaker, 1980: 
Kaufman & Bdrdny. 1981; Kaufman & Rentzhog, 1983; Kaufman.
1986) thus mediating finally a reduction in IOP. Anderson & 
Wilson (1990) reported that the topical application of 
adrenaline lowers IOP in the rabbit, although these authors 
also indicate that this is largely due to an increase in the 
facility of outflow. Further to these observations, however
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the specific 3-adrenoceptor agonist isoprenaline reduces IOP
in the human eye via a reduction in aqueous formation. In 
addition, topical application of the 32~adrenoceptor agonist
salbutamol to the human, feline or rabbit eye leads to a 
reduction in aqueous secretion (Langham & Diggs, 1974: 
Colasanti & Trotter. 1981). The effect can be blocked by 
pretreatment with propranolol or timolol, however. 
Gaasterland et al. (1973) reported that topical isoprenaline 
lowered both IOP and secretion rate in normal human 
volunteers, but had no effect upon the facility of outflow. 
In rabbits, topical isoprenaline was reported to decrease 
outflow facility in one case (Norton & Vierstein. 1972) and 
increase it in another (Langham & Diggs, 1974). Eakins 
(1963) injected isoprenaline into the vitreous and found 
that aqueous humour formation was depressed. When 
isoprenaline was perfused through the anterior chamber of 
monkey eyes, it was found to increase aqueous secretion and 
outflow facility, including uveoscleral drainage (Bill.
1970).
Timolol, and other 3-adrenoceptor antagonists, as will 
be seen lower IOP in the bovine arterially perfused eye. a 
preparation which lacks intact adrenergic innervation and 
therefore has no endogenous sympathetic tone for a 13- 
adrenoceptor antagonist to block, further suggesting that 
the mechanism of action of timolol upon IOP is not mediated 
via a classical 3-adrenoceptor.
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Another 3-adrenoceptor antagonist, carteolol, which is 
also used to lower IOP in patients with COAG, reportedly has 
1.67 times the potency of timolol for its extraocular 3- 
adrenoceptor binding response (Ishizaki et al.. 1983). 
However, carteolol is only 0.25 times as potent as timolol 
as an ocular hypotensive agent in the human eye (Horie et. 
al.. 1982).
If a 3-adrenoceptor is involved in the ocular response 
to IOP lowering drugs, it is likely to be atypical, perhaps 
both in structure and its post-receptor mechanism.
Vascular Effects of 3-Adrenoceptor Antagonists
The direct IOP-lowering effect of ocular 3-adrenoceptor 
antagonists is well documented. However, reducing IOP is 
poorly correlated with protecting against visual field loss 
(Vogel et al.. 1990; Schulzer et a 1.. 1991). It is now 
considered that other factors, such as ocular vascular 
effects play an important role (Chauhan et a 1.. 1989).
Unlike non-selective 3-adrenoceptor antagonists such as 
timolol, betaxolol has been shown to minimise long-term 
arteriolar constriction in the ciliary body and retina, thus 
permitting potentially normal ocular vasoregulation and 
perfusion (van Buskirk et al., 1990). Recent clinical 
evidence (Messmer et a 1., 1991) suggests that betaxolol is 
superior to timolol in preserving the visual field in
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glaucoma patients. However several workers have suggested 
that timolol and other 3-adrenoceptor antagonists actually 
reduce aqueous secretion via a modification of blood flow to 
specific structures within the uveal tract. In this 
respect, the effect of topically administered timolol on 
ocular blood flow has been studied in both the rabbit and 
human eye. A pretreatment for lh with 0.25% timolol has 
been observed to decrease blood flow in the iris root- 
ciliary body and the choroid of the rabbit whilst flow in 
the iris and retina was unchanged (Watanabe & Chiou, 1983). 
However, in a later study, 0.25% solutions of (-)-timolol or 
( + )-tirnolol did not affect regional blood flow in the rabbit 
eye (Chiou & Yan. 1986). A similar result was observed in a 
study in which 0.5% timolol was applied as eight drops, 
every 7.5 min. to the rabbit eye in the hour immediately 
preceding ocular blood flow determinations (Jay et al..
1984). Additionally, the three-tirnes daily instillation of 
0.5% timolol for 5 to 6 weeks had no effect on regional 
ocular blood flow in the rabbit (Green &. Hatchett. 1987). 
Conversely, Ernest & Goldstick (1983) found that timolol 
increased flow to the choroid in the human eye. A 
radiolabelled microsphere technique was utilised in all of 
these studies of ocular blood flow. Labelled microspheres 
offer the advantage to the investigator of being able to 
differentiate the responses of various subdivisions of a 
specific ocular vascular bed to the drugs under 
investigation. Inladdition to the labelled microsphere
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technique, unlabelled microspheres have also been used in an 
attempt to assess ocular blood flow (Geijer & Bill, 1979).
The techniques of Laser Doppler Velocimetry CRiva et 
a 1., 1985; Robinson et al., 1986), Oculo-Osci1lo- 
Dynamography (Urlich & Urlich, 1985), Ocular 
Pneumoplethsysmography (Gee et a l ., 1976), Compression 
Ophthalmodynamometry (Grunwald & Furubayashi, 1989) and 
Colour Doppler Ultrasound (Baxter et a l .. 1992) have also 
been used in attempts to measure ocular blood flow.
Other 3-Adrenoceptor Antagonists Used to Lower Intraocular
Pressure
The non-selective 3-adrenoceptor antagonist carteolol 
is in common clinical use in the treatment of COAG. Topical 
doses required to lower IOP with this drug however are 
higher than with those discussed previously with timolol; 
the twice-daily instillation of 1% and 2% solutions of 
carteolol are used to lower IOP in glaucoma patients. As 
with the other 3-adrenoceptor antagonists, carteolol 
mediates a reduction in IOP via a reduction in aqueous 
secretion (Araie & Takase. 1985). The drug is not 
considered to affect outflow facility (Gorgone et al .,
1983). Unlike the other 3-adrenoceptor antagonists used in 
the treatment of ocular hypertension, however, carteolol
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also possesses intrinsic sympathomimetic activity (Koch,
1983).
Laevobunolol is a 3i and 32 adrenergic antagonist which
was originally developed for the treatment of systemic 
hypertension and ischaemic heart disease (Arce-Gomez et a l ., 
1976; Bray, 1977; Shapiro & Park, 1978; Partamian et al.. 
1983). It is a potent 3-antagonist, structurally related to 
propranolol. The agent has no intrinsic sympathomimetic or 
local anaesthetic activity (Novack, 1986), and has a potency 
comparable to that of timolol. The drug is metabolised in 
the anterior segment of the eye to dihydrolaevobunolol (DHL) 
(Chen et a 1.. 1987; Tang-Liu et a 1.. 1987); the ability of 
£>HL to block ocular 3-adrenoceptors is comparable to that of 
laevobunolol (Woodward et al.. 1987). As with timolol, 
levels of laevobunolol after topical instillation are 
greater in the ICB of pigmented rabbit eyes as opposed to 
non-pigmented eyes (Chen et a 1.. 1988). Partamian et a l . 
(1983) noted a significant decrease in the IOP of glaucoma 
patients after the topical instillation of a single dose of 
0.03%. 0.3%. 0.6%. 1% or 2% laevobunolol. lasting for up to 
twelve hours after administration in the case of the 1% and 
2% concentrations. No side effects were noted, nor were any 
substantial changes in visual acuity, pupil diameter, pulse 
rate or blood pressure recorded. Repeated instillation of 
lower concentrations of laevobunolol is also reported as 
significantly lowering IOP in glaucoma patients. Bensinger 
et al . (1985) reported a mean reduction in IOP of 9.0 mrnHg
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compared with placebo treated control after the twice-daily 
instillation of 0.5% or 1% laevobunolol, over a three-month 
period. Similarly, Boozman et a 1. (1988) reported a mean
reduction in IOP of 5.1 mmHg in response to the twice-daily 
instillation of 0.25% or 0.5% laevobunolol, over a period of 
one year. Boozman also compared these concentrations of 
topical laevobunolol with the same concentrations of topical 
timolol: in the case of timolol, a similar mean reduction in 
IOP of 4.6 mmHg was found, over the same one-year period. 
Further studies upon the relative efficacy of laevobunolol 
and timolol have shown that the long-term, twice-daily 
instillation of 0.5% solutions of laevobunolol or timolol 
elicits a comparable reduction in the IOP of glaucoma 
patients (Berson et al., 1985: Long et a 1.. 1985). In 
contrast. 0.25% and 0.5% solutions of laevobunolol are more 
effective than 0.5% betaxolol on long-term administration 
(Long et al., 1988). The results of one study indicate that 
once-daily 0.5% laevobunolol is more effective than 
similarly administered timolol in controlling the IOP of 
glaucoma patients (Wandel et a l ., 1986). Surprisingly, 
laevobunolol has been found to be more effective than 
timolol in preventing post-operative ocular hypertension 
after cataract extraction (West et al.. 1988). In this 
respect, betaxolol was found to be ineffective. As with 
timolol, laevobunolol reduces IOP of glaucoma patients via a 
decrease in aqueous humour secretion (Yablonski et al.,
1987).
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Metipranolol is a non-selective 0-adrenoceptor 
antagonist a topical preparation of which has been licensed 
in the United Kingdom for the treatment of glaucoma since 
1986, although it has been in widespread use in Europe for 
many years, and in 1991 was marketed in the United States.
As with the other 0-adrenoceptor antagonists, the drug 
reduces IOP via a reduction in aqueous secretion. Topically 
applied metipranolol does not, however, mediate an ocular 
hypotensive effect upon the normal healthy eye (Sugrue et 
a 1.. 1985). The affinity profile of metipranolol as a 0- 
adrenoceptor antagonist is similar to that of propranolol 
(Sugrue et a l .. 1985). Mills and Wright (1986) observed 
similar reductions in IOP after 1 month twice-daily 
instillations of 0.3% metipranolol or 0.25% timolol.
Topical metipranolol is reported to yield a modest reduction 
in heart rate and blood pressure (Krieglstein et a 1.. 1987). 
Some authors believe, however, that metipranolol is less 
well tolerated than other topical 0-adrenoceptor 
antagonists, with a high incidence of side-effects (Kruse, 
1983: Krieglstein et a 1., 1987). Metipranolol has since 
been conclusively shown to cause granulomatous anterior 
uveitis, blepharoconjunctivitis and elevation in IOP 
(Akingbehin & Villada, 1992; Akingbehin et al., 1992), 
adverse effects never previously reported with any other of 
the ophthalmic 0-adrenoceptor antagonists. In consequence, 
the drug has now been withdrawn in the United Kingdom for 
the treatment of glaucoma.
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Other 3-adrenoceptor antagonists reported to possess 
ocular hypotensive activity include: oxprenolol and 
metoprolol (Lotti et al.. 1984), befunolol (Main & Tucker,
1985), bupranolol (Novack, 1987), pindolol (Bonomi & 
Steindler, 1975), labetalol (Murray et a l ., 1979). 
falintolol (Bouzoubaa et al . . 1984) and spirendolol 
(Nathanson. 1985b),
Inhibitors of Carbonic Anhydrase
Carbonic anhydrase inhibitors have been used in the 
treatment of open-angle glaucoma since the 1950's. Carbonic 
anhydrase has been shown to be present in both the pigmented 
and the non-pigmented ciliary epithelial cells of the rabbit 
(Muther & Friedland. 1980; Lutjen-Drecol1 & Lonnerholm,
1981). Becker (1954) noted that oral administration of the 
carbonic anhydrase inhibitor acetazolamide resulted in a 
reduction in aqueous secretion. Since this discovery, 
several members of this group of drugs have been utilised in 
the treatment of COAG, those being: acetazolamide. 
methazolamide. ethoxzolamide and dichlorphenamide. The 
drugs are given systemicallv, and in some cases lead to 
unpleasant side-effects. such as nausea and vomiting, or 
headache.
Vasodilator Drugs Which Lower Intraocular Pressure
In addition to 3-adrenoceptor antagonists, it has also 
been reported, somewhat surprisingly, that the vasorelaxant 
cardiac peptide atrial natriuretic factor (atriopeptin - 
AP). which inhibits cyclic AMP synthesis, will lower IOP in 
the rabbit (Sugrue & Viader. 1986) and human eye when 
topically applied, probably by slowing the rate of aqueous 
formation. AP is synthesised, stored and released by 
cardiac myocytes (deBold, 1985; Needleman & Greenwald,
1986). Extra-atrial sites of AP synthesis have been 
described (McKenzie et al.. 1985; Gardner et al., 1986), 
however no mRNA transcripts of AP have been localised in 
ocular tissue (Stone, 1987). These peptides have direct 
natriuretic, diuretic and vasodilatory properties (Currie et. 
al . , 1983; Maak et a 1.. 1986). The biochemical mechanism by 
which AP achieves a reduction in aqueous humour formation 
appears to be very different from that of the 3-adrenoceptor 
antagonists. AP promotes a rise in ciliary cyclic GMP 
(Fawcett & Wilson. 1989; Korenfeld & Becker. 1989). and 
indeed topical application of 8-bromo cyclic GMP (an 
analogue of cyclic GMP more resistant to hydrolysis by 
phosphodiesterases than cyclic GMP) reportedly lowers IOP in 
the rabbit (Becker. 1990). The effect is reportedly 
mediated by AP receptors (Nathanson, 1986), which have been 
detected in rabbit ciliary processes in high density by both 
autoradiography (Bianchi et al., 1986) and by guanylate
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cyclase stimulation studies (Mittag et al.. 1987; Nathanson,
1987). There is a lower density of AP receptors present in 
the choroid, ciliary musculature and retina. Additionally, 
intracameral and intravitreal injection of AP markedly 
lowers IOP of normotensive albino rabbits (Mittag et al ., 
1987: Nathanson. 1987). The AP receptor is coupled to a 
membrane-bound guanylate cyclase molecule (Waldman et al.. 
1984: Winquist et a 1. . 1984: Hamet et a 1.. 1986); recent 
evidence suggests that the AP receptor is more heterogeneous 
than was previously thought (Takayanagi et a l .. 1987; Budzik 
et a 1.. 1987; Shinjo et a 1., 1988). The evidence for the 
effects of other vasodilator drugs upon IOP is much less 
abundant.
However, there are also reports in the literature of 
the ocular effects of other classes of vasorelaxant drugs 
which mediate an increase in intracellular cyclic GMP 
concentration via activation of soluble guanylate cyclase; 
for example, several nitrovasodi1ators. These reports are 
conflicting, however. Topical instillation of a 0.03% 
solution of nitroglycerine activates ciliary guanylate 
cyclase in the rabbit eye, mediating a reduction in aqueous 
secretion and IOP (Nathanson. 1988). Further, i.v. infusion 
of SNP into patients resulted in both a decrease in systemic 
blood pressure and IOP (Karnezis & Murphy. 1988).
Conversely, topical administration of 1% or 2% solutions of 
sodium azide or SNP to rabbits were found to increase IOP in 
a dose-dependent manner (Krupin et al., 1977). Aqueous
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outflow facility, as measured by tonography was unchanged, 
as was systemic blood pressure and heart rate, suggesting an 
increase in aqueous flow as the mechanism for the increase 
in IOP. However, systemic pretreatment with the ol- 
adrenergic blocker phenoxybenzamine was found to prevent the 
rise in IOP, but not to affect the rise in aqueous humour 
cyclic GMP in response to these drugs, suggesting that an 
intact o^-adrenergic pathway is required for increased IOP 
following sodium azide or SNP.
Sodium azide is thought to directly stimulate an 
intracellular soluble guanylate cyclase, and also promotes 
the release of endothelial derived relaxing factor - EDRF 
(Furchgott & Zawadzki, 1980) from blood vessel endothelia, 
since shown to be nitric oxide (Palmer et al., 1987). SNP 
also directly stimulates a soluble guanylate cyclase enzyme, 
but has no effect upon secretion of EDRF. ACh promotes the 
production and release of EDRF from vascular endothelium, by 
activation of the enzyme nitric oxide synthase, the enzyme 
responsible for the production of EDRF from L-arginine. It 
does so via binding to endothelial muscarinic receptors.
EDRF is then taken up by vascular smooth muscle cells, 
whereupon it mediates vascular relaxation by stimulation of 
a soluble guanylate cyclase, leading to an increase in 
sarcoplasmic cyclic GMP which activates a cyclic GMP 
dependent protein kinase. This in turn elicits an 
inhibition of release of Ca^+ from the sarcoplasmic 
reticulum, increases the rate of uptake of Ca^+ by the
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sarcoplasmic reticulum, and increases the rate of extrusion 
of Ca2+ from the cell across the plasma membrane (Murad,
1986). This promotes vascular smooth muscle relaxation and 
vasodilation. The ocular vascular endothelium may produce 
EDRF. Since EDRF stimulates intracellular soluble guanylate 
cyclase, it may be involved in the control of aqueous 
secretion.
There are reports of similar ocular effects of other 
classes of vasorelaxant compounds, for example, a variety of 
L-type Ca2+ channel antagonists. Topical nifedipine (0.01%. 
0.1%, 0.5% & 1%), topical verapamil (0.01%. 0.05%, 0.1% & 
0.25%) and topical diltiazem (0.1%, 0.5% & 1.0%) had no 
significant effect upon IOP in rabbits (Payne et al.. 1990). 
but when given systemically, verapamil (0.1 mg/kg) and 
nifedipine (0.33 mg/kg) yielded a significant reduction in 
IOP between 2 and 6h after administration, the nifedipine 
response, however following a significant increase in IOP 
after 30 min. Intravenous diltiazem (1 mg/kg), given three 
times daily for three days, produced no change in IOP. The 
ocular hypotensive effect of topical nifedipine (Kelly & 
Walley, 1988) and verapamil (Abelson et al., 1988) upon the 
human eye have been demonstrated, however. Conversely. 
Beatty et a l . (1984) reported an increase in IOP in response 
to topical diltiazem and verapamil in human volunteers.
Certain vasodilator drugs which mediate a decrease in 
intracellular free potassium ion via the opening of plasma- 
membrane ATP-sensitive potassium channels, are also reported
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as producing a concomitant decrease in intracellular free 
calcium ion. in several examples of vascular smooth muscle, 
for example, rabbit aortic smooth muscle (Gelband et al., 
1988; Bray et al.. 1991), rabbit superior mesenteric artery 
smooth muscle (Meisheri et al.. 1991) and rat portal vein 
smooth muscle (Hamilton et al.. 1986; Hu et a l .. 1990).
There is little published in the literature to date 
concerning their ocular effects, however certain drugs of 
this class are known to reduce IOP in the bovine perfused 
eye preparation (Millar & Wilson. 1992).
It has been suggested that dopaminergic mechanisms may 
play a role in the ocular hypotensive effect of timolol 
(Watanabe & Chiou. 1983). Dopamine is a known 
neurotransmitter in the retina, but its actions elsewhere in 
the eye have not been recognised until recently, when 
studies in animals and humans have indicated that it may be 
involved in control of IOP (Kramer, 1971). The topical 
administration of the DA2 agonists bromocriptine, lergotrile
or pergolide to rabbits results in a reduction in IOP, with 
pergolide exhibiting the greatest ocular hypotensive 
activity. Of these three compounds, however, bromocriptine 
does not lower the IOP of normal monkeys. The ocular 
hypotensive action of these compounds in rabbits is mediated 
via a reduction in aqueous secretion (Leopold & Duzman,
1986). Moreover, their ability to lower IOP in the rabbit 
is blocked by superior cervical ganglionectomy, or by 
pretreatment with the DA2 antagonist domperidone (Potter et
a l .. 1984). Domperidone Itself has no reported effect upon
IOP. Pergolide has also been shown to lower the IOP of
cynomolgous monkeys (Siegel et a l .. 1987). Both orally and
topically administered bromocriptine lowers the IOP of human
volunteers (Mekki et al., 1984). and oral bromocriptine
lowers the IOP of glaucoma patients (Lustig, 1983; Geyer et.
a l .. 1987). In contrast, the ocular hypotensive effect of
timolol in healthy human individuals is unaltered by a 
previous intravenous injection of the DA2 antagonist
metoclopramide (Mekki & Turner. 1988). thus indicating that
the ocular hypotensive effect of timolol is probably not
mediated via a dopaminergic mechanism.
Turner and Mekki (1985) suggest that the mechanism of
action of dopamine agonists in the modulation of IOP may 
involve presynaptic BA2 receptor stimulation of
noradrenergic nerve endings in the ciliary body. However, 
subsequent binding assays for ocular DA2 receptors have been
performed in the rabbit using ^H-spiroperidol (Mallorga &
Sugrue. 1987), but none have been found, either in the
ciliary tissue or elsewhere in the eye. Experimental 
evidence suggests the existence of DA^ receptors in human
and bovine ciliary tissue (De Vries et a l .. 1986). In one 
study, infusion of the selective DA^ receptor agonist
fenoldopam (0 .5ugkg“l.min“l) in normal human volunteers 
elevated IOP by 24% without altering systemic blood pressure 
(Karnezis et a 1., 1987). Comparison of the effects of 
fenoldopam with the vasodilator SNP in patients showed that.
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whilst both drugs reduced blood pressure, fenoldopam 
increased, wheras SNP decreased, IOP. In another study (De 
Vries et al.. 1986), fenoldopam induced a dose-dependent 
increase in intracellular cyclic AMP content in bovine and 
human ciliary processes. Pretreatment with the selective 
DAj receptor antagonist SK&F-83566 inhibited the latter
response. The recent isolation from the non-pigmented
ciliary epithelium of the regulatory phosphoproteiri of
cyclic AMP, DARPP-32. a protein previously found only in 
cells bearing large numbers of DA^ receptors, further
supports the presence of these receptors in the ciliary 
processes.
Other Agents Which Lower Intraocular Pressure
There are a wide variety of other agents which 
reportedly lower IOP. These include directly acting 
cholinergic agonists, such as pilocarpine, carbachol and 
aceclidine (Havener. 1983) as well as the reversible 
anticholinesterases physostigmine, demecarium, ecothiophate 
and isofluorophate (Leopold. 1984). a£-adrenoceptor agonists 
such as clonidine (Harrison & Kaufmann. 1977: Hodapp et a l .. 
1981) and apraclonidine (Abrams et al., 1987), and 
antagonists such as prazosin (Krupin et al., 1980), 
yohimbine (Mittag et a l .. 1985), dibenamine, phentolamine, 
phenoxybenzamine and thymoxamine (Mittag, 1983) reportedly
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lower IOP in animal experiments. Selected prostaglandins
(Camras et al., 1977), ACE inhibitors such as captopril,
enalapril and SCH 33861 (Watkins et al., 1987), the 5-HT
antagonist ketanserin (Chang et al .. 1985; Krootila et al..
1987), glucocorticoids (Becker, 1965), H^-antihistamines
such as antazoline and pyrilamine (Krupin et a l .. 1980), 
colchicine (Bhattacherjee & Eakins, 1978) and a component of 
marijuana, ^-tetrahydrocannabinol (Purnell & Gregg, 1975), 
also are reported to possess ocular hypotensive activity.
The Isolated Arterially Perfused Eve
To date, most studies concerning the effects of drugs 
upon aqueous humour dynamics and IOP have been conducted in 
vivo upon a number of different animal species, and in the 
human. Such studies are complicated by the influence of the 
central nervous system (CNS), the endocrine system and the 
cardiovascular system (CVS) upon secretion and/or drainage 
of aqueous. However, several workers, in order to obviate 
such complications in the interpretation of data, have used 
as an experimental model, the isolated arterially perfused 
eye from a number of species, including rabbit (Kodama et 
al . . 1983, 1985). cat (Macri & Cevario, 1973, 1974; Helal et 
a l ., 1979; Macri et al.. 1980: van Alphen & Macri, 1981; van 
Alphen et a 1.. 1982) and bovine (Kishida et al.. 1985; 
Wilson, 1988). The isolated perfused eye lends itself to
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the direct correlation of drug effects on IOP, aqueous 
humour formation, the uveal vasculature and the patency of 
the blood-aqueous barrier. Additionally, it permits 
experimental manipulation of perfusion media. Wilson 
describes the bovine arterially perfused eye as an 
experimental model upon which timolol will reduce IOP. 
Isolation of the eye from the influence of the CNS and hence 
sympathetic and parasympathetic tone is particularly 
important when studying the ocular effects of the 3- 
adrenoceptor antagonists (as opposed to agonists).
Isolation of the eye from the effects of the CVS is also 
important since changes in systemic blood pressure (and 
hence systemic effects of drugs under investigation) can 
affect aqueous secretion rate and therefore IOP. Isolation 
of the eye from the endocrine system is also important, as 
certain hormones are known to have an effect upon aqueous 
humour dynamics.
There is a long history in the literature on the study 
of the ocular cyclic AMP response to various B-adrenoceptor 
agonists, antagonists and other compounds, as measured in 
ciliary tissue and the aqueous (Bhargava et a 1.. 1980; 
Nathanson. 1980; Boas et al., 1981; Cepelik & Cernohorsky, 
1981; Liu et a 1., 1983; Elena et a l ., 1984a; Mittag &
Tormay. 1985: Bartels et al., 1987; Kintz et al .. 1988). 
Other work with AP (Sugrue & Viader, 1986; Mittag et a 1.. 
1987; Nathanson, 1987; Fawcett & Wilson, 1989; Korenfeld & 
Becker. 1989) and nitrovasodilators (Krupin et a 1.. 1977)
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has indicated a possible involvement of cyclic GMP as
another candidate for an intracellular second messenger
involved in the ocular response. (3-adrenergic receptors are
positively coupled to the generation of intracellular cyclic 
AMP via a membrane bound Gs protein, associated with adenyl
cyclase, also bound to the cell membrane (Fig.17). When an
agonist binds to the receptor, the agonist-receptor complex 
so formed causes a conformational change in the adjacent Gs
protein, which promotes the binding of the Gs protein to
intracellular GTP. The Gs protein-GTP complex then
activates the adenyl cyclase molecule, leading to an 
increase in the concentration of intracellular cyclic AMP. 
formed from the hydrolysis of cytoplasmic ATP. The cyclic 
AMP formed then binds to cytoplasmic cyclic AMP dependent 
protein kinases, thus activating them and promoting various 
intracellular phosphorylation reactions leading to many 
different effects, depending upon the cell type. Cyclic AMP 
may also directly decrease the release of Ca^+ from 
intracellular stores - this effect is especially seen in 
muscle cells, and the resultant effect here is inhibition of 
muscle cell contraction. In this context. Ca^+ also acts as 
a second messenger. This is how the binding of the ID- 
adrenergic receptor by a molecule of agonist is translated 
into a cellular response. The intracellular cyclic AMP 
formed is hydrolysed by cytoplasmic cyclic AMP 
phosphodiesterase (PDE), thus limiting its effects.
Receptors coupled to guanylate cyclase (such as AP
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Fig.17. Formation of intracellular cyclic AMP as a
consequence of agonist - receptor interaction 
(After Stryer, Biochemistry. 2nd Edition).
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receptors) mediate a rise in intracellular cyclic GMP in a 
similar fashion. The role of cyclic GMP in certain 
physiological processes has only become apparent since 1978 
(Murad & Aurbach. 1978; Murad et al.. 1979; Mittal & Murad. 
1982; Rapoport & Murad. 1983). This is probably a 
consequence of the low concentration of the nucleotide in 
tissues, the complex and insensitive methods available 
during the early studies, and the biases many investigators 
had regarding its possible functions. The latter was 
undoubtedly influenced by the many similarities of the 
cyclic GMP system with the cyclic AMP system, and the 
attenuation cyclic AMP has received during this period. 
Whilst analogies and similarities between these two cyclic 
nucleotide systems do exist, the cyclic GMP system presents 
more complexities due to the existence of several isozymes 
responsible for its synthesis.
Certain other receptor types, such as oC^—
adrenoceptors, are coupled to the production of 
intracellular inositol trisphosphate (IP3) and membrane
diacylglycerol (DAG), from the membrane phospholipid 
precursor phosphatidyl inositol bisphosphate (PIP2). The 
other intracellular second messengers. Ca^+ and PIP2 . which 
represent almost universal intracellular second messengers 
in many tissues, do not appear to have been investigated at 
all with regard to the IOP lowering effect of ocular 
hypotensive drugs. It seems that an investigation of some 
of these other possibilities would now be appropriate. The
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bovine perfused eye preparation offers the opportunity to do 
this, more especially since the preparation facilitates the 
rapid access to substantial amounts of living tissue, thus 
enabling the investigator to relate physiological responses 
to biochemical events.
The isolated arterially perfused eye was chosen as an 
experimental model for the reasons related above; the bovine 
species was selected primarily for reasons of availability 
and cost. Additionally, the bovine eye is large and thus 
relatively straightforward to set up experimentally as an 
isolated perfused eye preparation: smaller eyes from other 
species are in practice much more difficult due to the small 
size and inaccessibility of the blood vessels.
Aims of Project
There is a great need for an in vitro animal model for 
use in studies on aqueous humour dynamics, and its potential 
pharmacological manipulation, particularly as the anti­
animal experimentation lobby continues to gain momentum. 
Since there will be progressively more restrictions applied 
to the sacrificing of animals for experimental purposes, 
such in vitro models will almost certainly become more 
important in the future, especially in such an emotive area 
as ocular research. The aims of this project were to 
develop and improve the method of Wilson (1988), so that the
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isolated perfused bovine eye preparation could be utilised 
for the routine screening and comparison of drugs for 
possible IOP lowering effect. Further, an investigation of 
the pharmacological mechanisms governing aqueous secretion 
was undertaken, by way of a study of the effect of a number 
of ^-adrenoceptor antagonists of upon IOP in the isolated 
perfused bovine eye, which reportedly reduce the rate of 
secretion of aqueous humour but by an anomalous mechanism. 
The finding that the vasoactive drug AP lowered IOP in this 
model, probably via a novel biochemical mechanism prompted 
closer analysis of this effect to determine whether the 
effect on IOP was a primary one or secondary to the vascular 
changes induced by the drug, especially with a view to 
determining, if vasodilatation is not involved in the 
lowering of IOP. whether the cellular mechanism is the same 
in blood vessels as in the ciliary processes. The isolated
perfused bovine eye provides an ideal experimental model for
such investigation. Additionally, in view of the conflict 
in the literature, an investigation of the ocular effects of 
other classes of vasodilators was undertaken, specifically, 
selected nitrovasodilators, and drugs reported to decrease 
intracellular Ca2+, in order to investigate the possibility 
that a novel IOP lowering mechanism might be found. The 
effect of selected ocular hypotensive drugs upon ciliary 
cyclic GMP was investigated.
An attempt was also made to differentiate the vascular
effects of some of these drugs with respect to the various
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subdivisions of the ciliary vascular bed in the isolated 
perfused bovine eye by the use of radiolabelled 
microspheres. The technique of utilising labelled 
microspheres for the estimation of blood flow through a 
tissue or organ is not new. Numerous studies have been 
carried out, including estimations of cardiac output 
distribution in the foetal sheep and goat (Rudolph &
Heymann. 1967). rabbits (Neutze et al .. 1968), dogs (Kaihara 
et. al . , 1968) and rats (Sasaki & Wagner, 1971) . More 
recently, there have been studies to measure intrarenal 
blood flow in the dog (Katz et al.. 1971), cochlear blood 
flow in the rat (Hillerdal et al .. 1987), and coronary flow 
in the cat and rabbit (Hof et a 1.. 1981). dog (Hale et al ..
1988) and rat (Wicker & Healy, 1989). Ocular blood flow 
measurements have also been undertaken utilising this 
technique, for example, in the rabbit (Morgan et a 1.. 1981; 
Watanabe & Chiou, 1983; Chiou & Yan, 1986), the monkey 
(Caprioli et a l ., 1984), the dog (Roy et al .. 1989) and the 
cat (Oksala. 1988). However, in all of the previous 
studies, blood flow was measured in vivo. Several authors 
deal with the theoretical and practical considerations when 
utilising labelled microspheres, and potential sources of 
error (Buckberg et al.. 1974: Warren & Ledingham, 1974), 
however the use of labelled microspheres to estimate flow to 
various parts of an organ perfused in vitro does not appear 
to have been described elsewhere.
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A comparison of the effects of the various ocular 
hypotensive drugs investigated upon the divisions of the 
uveal vasculature of the isolated perfused eye, with the 
results reported in vivo was sought. The isolated perfused 
bovine eye offers the opportunity to develop this area of 
investigation.
METHODS
The Bovine Perfused Eye Preparation
Bovine eyes obtained from a local abattoir were
maintained at room temperature and transported to the
laboratory. They were not placed on ice, since the
resulting solidity of the orbital fatty tissues seriously
hampered dissection and cannulation. It was also felt that
the return of the eyes' core temperature to 37°C would be
slowed considerably by cooling the whole eye in ice.
Ambient temperatures during transportation were in the range
2 to 17°C, depending on seasonal variation. Within lh of
slaughter they were trimmed of adnexal tissue, taking care
not to damage the blood vessels of the retrobulbar
vasculature. A few mm of each extraocular muscle was left
attached to the globe. One of the long posterior ciliary
arteries (medial or lateral) was cleared of connective
tissue and cannulated distal to the point at which the
retinal artery leaves the ophthalmic artery but proximal to
the heavy pigmentation which appears in the arterial wall
before it enters the sclera (Fig.18). The eye was placed on
a jacketed holder maintained at 37*C and covered with a
polycarbonate cup to prevent drying. The long posterior
ciliary artery and thus the blood vessels of the choroid.
ciliary body and iris were then perfused with a Krebs 
solution comprising (mM): NaCl 118; KC1 4.7; CaCl2 2.5;
MgS04 1.2; KH2P04 1.2; NaHC03 25; glucose 11.5. The
solution was bubbled with a mixture of 02 :C02 (95:5), which
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Fig.18. The Bovine Arterially Perfused Eye Preparation.
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brought the pH to 7.4. Flow was induced in this solution by 
a Watson-Marlow peristaltic perfusion pump fitted with a 
502S pumphead. Arterial perfusion pressure was recorded via 
a pressure transducer and Linseis pen recorder, and flow 
rate was increased in 0.225 mlmin- -^ increments until 
reaching 2.25 ml.rnin-1 . over a period of approx. 50 min. 
During this period, perfusion pressure often fluctuated but 
the flow rate was adjusted to prevent the pressure from 
exceeding 100 mmHg. Successful perfusion was signalled by 
the appearance of small amounts of blood from the cut ends 
of the vortex veins: on occasion it was necessary to cut 
away the remnants of the extraocular muscles in order to 
encourage visible flow. After approx. 50 min. when aqueous 
humour secretion had started and the globe had become firm, 
the anterior chamber was cannulated with a 23 gauge steel 
needle, and connected via a fine silicon tube of internal 
diameter 1 mm to a water manometer. Observations of IOP 
were usually made at 5 min intervals throughout the
remainder of the experiment. Only eyes maintaining a stable 
IOP within the range 95 to 150 mntf^O (7 to 11 mmHg) , and a
stable arterial perfusion pressure within the range 20 to 60 
mmHg. after an equilibration period of a further hour were 
accepted for study. At this point, bolus doses of drugs or 
vehicle solution could be injected immediately proximal to 
the arterial cannula, and their effects upon both IOP and 
arterial perfusion pressure could be measured and recorded.
Effects of 3-Adrenoceptor Antagonists on IOP
In order to confirm that the bovine isolated perfused 
eye preparation is able to demonstrate significant and 
reproducible ocular effects of specific drugs, a selection 
of 3-adrenoceptor antagonists, including some of those 
utilised in the treatment of COAG, were tested in this 
preparation. Isolated perfused eye preparations were set up 
and. after equilibration of arterial perfusion pressure and 
IOP, the latter was recorded every 5 min for a period of 15 
min, to ensure that it did not fluctuate by more than 0.5 
mmH20. Upon establishing that IOP was thus stable, a bolus
injection of 3nmol (3ul of 10-3 M) cf a solution of a 3- 
adrenoceptor antagonist dissolved in Krebs solution was 
injected into the arterial perfusate, proximal to the 
arterial cannula through self sealing tubing, using a 
Hamilton Microsyringe. The time of injection was designated 
time zero: IOP measurements were recorded every 5 min 
thereafter for a period of 20 min. At 20 min. a lOnmol 
flOul of 10-3 M) bolus injection was given; continued 
measurements of IOP were made every 5 min until 40 min from 
time zero, whereupon a further bolus, dose of 30nmol (30ul of 
10-3 M) was injected. IOP was recorded up to and including 
60 min from time zero. The 3-adrenoceptor antagonists 
tested in this way were: timolol, oxprenolol. betaxolol. 
laevobunolol, DHL. carteolol. metoprolol and metipranolol. 
Results were compared with control experiments in different
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eyes where saline in volumes of 3, 10 and 30jli1 were injected 
at time zero. 20 and 40 min respectively.
Effect of Acetazolamide on IOP
Bovine eye preparations were set up as previously; 
vascular perfusion pressure and IOP was allowed to 
equilibrate. Acetazolamide. dissolved in saline was 
injected into the perfusate as bolus doses of 0.3. 1 and 
3umol (3. 10 and 30ul 10“ ^ M) at time zero. 20 and 40 min 
respectively. The effect upon IOP. measured every 5 min, 
was recorded.
Effect of Dopamine Agonist FPL 65879AA on IOP
The experimental protocol utilised was as that 
described previously for acetazolamide, except that FPL 
65879AA was given in various bolus dosages of: 30, 100 and 
SOOnmol, and 1, 3, 10 and 30umol.
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Single Dose Timolol: IOP-Time Curve
This procedure was carried out in an attempt to 
determine the absolute change in IOP in response to a single 
dose of timolol. The experimental protocol was similar to 
that described above for the 3-adrenoceptor antagonists, 
except that in this case only timolol was utilised, and was 
injected only once, as a single bolus dose of lOnmol at time 
zero. IOP was subsequently recorded for a period of 100 
min, at 5 min intervals. Results were compared with control 
experiments in which saline was injected.
Log Dose-Response Curves for IOP Effects of Timolol and
Carteolol
In this procedure, single bolus doses of timolol or 
carteolol were injected and IOP recorded every 5 min for a 
period of 100 min from time zero, as in the previous 
procedure described for the single dose of timolol. In this 
case, however, the absolute effect of a range of different 
doses upon IOP over time was established for each of the two 
drugs. This was undertaken with a view to the production of 
log dose-response curves for the effect of each specific 
single bolus dose of timolol or carteolol upon IOP. The 
bolus doses of timolol and carteolol utilised were: 0.03. 
0.3. 1. 3. 10 and 30nmol, in volumes of 1 up to 30ul.
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Effect of Atriopeptin (AP) on IOP
The experimental protocol was as per that described 
above for the 3-adrenoceptor antagonists, using AP (rat; 
fragment 1-27) dissolved in Krebs solution. A lOpmol (lOul 
of 10-t> M) bolus injection of AP was given at time zero, 
followed 40 min later by a 50pmol (50ul of 10-6 M) bolus 
dose. Only 2 doses of AP were thus given. IOP was recorded 
every 5 min for a period of 80 min. Once again, results 
were compared with control experiments in which saline was 
injected at corresponding time intervals and volumes.
Effect of AP on Ciliary Artery Perfusion
Isolated perfused eye preparations were set up and 
allowed to reach stable IOP and perfusion pressure. 
Noradrenaline bitartrate was added to the perfusate 
reservoir at a final concentration of 10-^ M, thus causing 
an increase in vascular tone and hence vascular perfusion 
pressure, at constant perfusate flow rate. Upon attainment 
of a stable degree of vascular tone, bolus injections of 10, 
30 and lOOpmol AP (1. 3 and lOjul 10~^ M) were given, 
allowing full recovery of vascular tone after one dose 
before proceeding to the next. Results were compared with
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experiments in which bolus injections of 0.3 and 3nmol (3ul 
of 10-4 M, and 3ul of 10“3 M) sodium azide (a potent 
vasodilator), were given, and also control experiments in 
which saline was injected in volumes of 3 and lOjul.
Effects of Other Vasodilator Drugs on Ciliary Artery
Perfusion
In addition to AP , the vascular effects of other 
classes of vasodilator drug were investigated. Perfused 
eyes were set up. and after equilibration noradrenaline 
bitartrate was added to the perfusate reservoir at a final 
concentration of 10“^ M, in order to increase uveal vascular 
tone, as described in the ciliary artery perfusion 
investigation for AP . After attainment of stable vascular 
tone, bolus doses of each drug were given in volumes of 1 ,
3. 10 and 30ul (ranging from 0.01 to 3000nmol. depending 
upon the particular drug), and the reduction in vascular 
tone induced by each dose of drug was determined. Results 
were compared with control experiments in which saline was 
injected in similar volumes.
71
IOP Effects of Other Vasodilator Drugs
This procedure was Identical to that previously 
described for the Log Dose-Response curves for IOP effects 
of timolol and carteolol, except that in this case the 
ocular effects of the nitrovasodilators sodium azide and 
SNP. and the potassium channel agonist pinacidil were 
investigated. Doses utilised were as follows: sodium azide; 
0.01 to 30nmol in log increments (all in volumes of 1 or 
3ul): SNP: 0.3 to lOOOnmol in log increments (all in volumes 
of 1. 3 or lOul); pinacidil; 3 to 3000nmol in log increments 
(all in volumes of 1, 3 or lO/il). After each single dose of 
vasodilator drug, IOP was recorded every 5 min for 165 min.
Investigation of EDRF Production by Uveal Vascular
Endothelium
In order to investigate the possibility that the uveal 
vascular endothelium produces EDRF, eyes were perfused with 
Krebs solution containing noradrenaline at 10“^ M 
concentration. Upon attainment of a stable degree of 
vascular tone, bolus injections of ACh were given, ranging 
from 30pmol to O.ljumol (3ul 10“  ^M to lul lCP^ M) in log 
increments. Full recovery of vascular tone was allowed 
after each dose of ACh before proceeding to the next dose. 
L-NOARG was then added to the Krebs solution at 3X10“  ^M,
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and allowed to perfuse until attainment of stable vascular 
tone once more, whereupon vascular relaxation responses to 
each bolus dose of ACh was determined once more. Results 
were compared with control procedures where saline was 
injected in volumes of 3 and lOul.
Ciliary Cyclic GMP Determinations
In order to determine the effects of the vasodilators 
AP and sodium azide upon cyclic GMP in the ciliary 
epithelium, perfused eye preparations were set up and 
allowed to achieve stability. Each eye was then challenged 
with a bolus dose of AP or sodium azide, known from previous 
experiments to be sufficient to lower IOP, or of saline 
control. Perfusion was allowed to continue for precisely 2 
min more, whereupon perfusion was stopped and the eye was 
rapidly dissected to remove the: sclera posterior to the ora 
serrata, the choroid and retina, vitreous, lens and lens 
capsule. The anterior portion of the sclera, cornea and 
ciliary body remaining was then inverted over a plasticine 
sphere which filled the anterior chamber and immersed in 
liquid nitrogen for 20s, thus effectively halting all 
chemical or enzymically catalysed reactions. The time 
between stopping perfusion and immersion in liquid nitrogen 
was approx. 3 min. After removal from the liquid nitrogen, 
the anterior eye portions were placed in a freezer at -30*C
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for a period of 20 min. They were then removed and the
superficial tissue, largely ciliary epithelial cells were
carefully scraped from the ciliary body in the region of the
pars plicata. taking care to harvest as little as possible
of the underlying stroma. The scraped epithelial cells were
then placed in Eppendorf tubes containing 1ml 6% TCA, and
stored at -30 *C until required. The tissue was thoroughly
disrupted by subjecting it to a thrice freeze-thaw-
sonication procedure. Sonication consisted of 5 min in a
Camlab Transsonic T310 sonicator bath. The resulting
homogenate was centrifuged at 20000g.min in a DAMON/IEC DPR-
6000 centrifuge, and the supernatant layered on top of 1 .6ml
of a solution of tri-N-octylamine (22.5% v/v) in freon, in a
3ml glass test tube. This was vortex-mixed thoroughly for
20s, then briefly centrifuged to clarify the seperate
phases. The supernatant was then transferred to a 0.5x6cm
column of Dowex-50W 50X8-100 mesh cation exchange resin
(hydrogen form) which had been washed 4 times in distilled 
H2O. The eluate from this column, after discarding the dead
volume, was collected (approx. 8ml), and evaporated to 
dryness and subsequently stored at -30°C. The dead volume 
and eluate volume were previously determined using standard 
3H-cyclic GMP. 0.5 ml of TCA were mixed with 0.1ml ^H- 
cyclic GMP. and the mixture was then added to 1.6ml tri-N— 
octylamine in freon in a 3ml glass test tube. The tube was 
then vortex mixed for 20s and then centrifuged at 
20000g.min. 0.4ml of supernatant was then transferred to a
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Dowex-50W 50X8-100 mesh cation exchange resin (hydrogen
form), and the resulting eluate collected in a 10ml plastic
liquid scintillation counting vial. The 0.2ml of
supernatant still remaining in the tube containing the tri-
N-octylamine in freon was then transferred to the same
column and the eluate collected in another counting vial. 
The column was then washed with 8x 0.5ml distilled H2O, and
each of the 8 eluates were collected in seperate vials. 10 
ml of Ecoscint scintillation cocktail was added to each of 
the ten vials, and the 3 radiation counted in a Packard 
2000CA Tri-Carb Liquid Scintillation Counter. The liquid 
scintillation counter included an automatic correction for 
counting efficiency.
The concentration of cyclic GMP present in each sample 
was estimated via the technique of cyclic GMP RIA, using a 
kit. Each dried extract was redissolved in 500ul of 0.05M 
sodium acetate buffer, pH 6.2. The principle of the assay 
is the competition between radioactive and non-radioactive 
antigen for a fixed number of antibody binding sites. This 
interaction is represented schematically below:
Labeled Antigen + Specific .Antibody ^—It Labeled .Antigen
Ag* Ab .Antibody Complex
Ag*Ab
'inlabeled Antigen
Ag tin standard solutions
or unknown samples)tl
TJ n la.be led .An t igen - An t ibody Comp le x
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If increasing amounts of non-radioactive antigen (e.g. 
standards or unknowns) and a fixed amount of radioactive 
antigen are allowed to react with a constant amount of 
antibody, a decreasing amount of radioactive antigen is 
bound to the antibody. This relationship can be expressed 
as a standard curve and the amount of unlabeled antigen in a 
sample determined from this curve. Seperation of bound from 
free antigen is achieved via centrifugation followed by 
aspiration of the supernatant, containing the free antigen. 
The labeled antigen utilised in the kit is ^^1-cyclic GMP. 
Harper and Brooker (1975) and Frandsen and Krishna (1976) 
demonstrated that acetylating cyclic GMP samples with acetic 
acid anhydride at the 2 1-O-position to yield 2 '-O-acetyl 
cyclic GMP resulted in a better antibody binding reaction, 
and thus the substituted cyclic GMP displaced the 125j_ 
labeled derivative more efficiently than the unsubstituted 
cyclic nucleotide. Therefore the acetylated samples method 
was utilised throughout. The standard curve was prepared 
according to the acetylated samples protocol supplied with 
the kit. Duplicate samples were run throughout. Internal 
standards were utilised to determine recovery efficiency per 
sample from its respective Dowex column. This was achieved 
by adding 1500 dpm of ^H-cyclic qmP to each spun-down tissue 
pellet in 0.5ml TCA, immediately prior to cyclic nucleotide 
extraction. The added ^H-cyclic GMP standard was subtracted 
from the final result for the calculation of cyclic GMP per
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sample. After extraction, evaporation and redissolving, 
lOOul of the redissolved extract was placed in a 10ml 
plastic liquid scintillation vial, and 10ml Ecoscint. 
scintillation cocktail was added. The 3 radiation was then 
counted in the same liquid scintillation counter as 
mentioned above, to determine the dpm. The resultant dpm 
per vial was multiplied by 5, and the recovery efficiency 
per sample calculated.
After incubation in a refrigerator at +4°C for 18h. all 
tubes were decanted and blotted on absorbent paper until 
dry. All tubes, including standards and blanks, were then 
counted on a Packard Cobra Auto-Gamma gamma counter. The 
gamma counter had a computerised calculation of fmol cyclic 
GMP per sample incorporated into its programming, which 
included a correction for counting efficiency.
Total protein present in the ciliary epithelial cell 
tissue residue saved from the initial cyclic nucleotide 
extraction was estimated by the method of Lowry et al.
(1951). To extract the total protein present, the pellet 
from the centrifugation was transferred to a 10ml glass test 
tube and dissolved in 5ml N-NaOH, by heating in a water bath 
at 60°C with occasional mixing for 2h. The protein assay 
was performed in triplicate (using 20. 30 and 50ul aliquots 
from each sample) within 3h of extraction. Tissue samples 
were compared with BSA standards and a blank.
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Drug Effects on Vascular Flow Using Radiolabelled
Microspheres
In order to determine how various drugs affect the 
distribution of blood flow within the anterior eye, a 
radiolabelled microsphere technique was adopted. For 
infusion of microspheres, a two-way apparatus (Fig.19) was 
constructed immediately proximal to the arterial cannula 
whereby a pre-prepared bolus of spheres could be loaded into 
the system, and subsequently injected into the eye at a 
suitable point in the procedure without interruption of flow 
or sudden increase in pressure (after administration of 
either drug or saline control), via the activation of a two- 
way valve. After attainment of full flow rate, 
noradrenaline bitartrate was added to the perfusate 
reservoir at a final concentration of 10“^ M, thus causing 
an increase in vascular tone. (The concentration of 
noradrenaline chosen was known to be such as to elicit 
submaximal uveal vasoconstriction). At this point, a bolus 
of approximately 4500 carbonized latex l^Ce-label led 15/im 
spheres, suspended in lOOul saline containing 0.01% Tween- 
80, to prevent aggregation of the spheres, and 0.009% benzyl 
alcohol as a bacteriostat. was agitated on a vortex mixer 
for a full minute and then loaded into the two-way system 
behind the arterial cannula. The eye was then treated with 
either drug, or 30ul saline control injected as a single 
bolus behind the cannula, and left for up to 1 min until the
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Fig.19. Microsphere Infusion Apparatus.
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full extent of the effect of the drug could be seen on the 
pen recorder Indicating vascular perfusion pressure. In the 
case of timolol or carteolol. bolus doses were chosen 
(30nmol) which are known to have maximal ocular hypotensive 
effect on this preparation. In the case of SNP and 
verapamil, doses which are known to elicit maximal uveal 
vasodilatation (300nmol) were utilised. After development 
of the full drug effect, the preloaded bolus of spheres was 
introduced into the eye and allowed to perfuse for a period 
of 5 min. The eye was then taken down from the perfusion 
apparatus and dissected to remove the: cornea, iris, ciliary 
body, lens, vitreous, aqueous, choroid/sclera (seperation of 
these two structures was found to be impractical), retina 
and extra-ocular muscle. Each component was then placed in 
a preweighed glass scintillation vial, the weight of the 
vial plus contents determined, and then counted on a Packard 
5355 gamma counter in order to determine cpm/g tissue (wet 
weight). Results were compared with additional experiments 
in which eyes perfused with Krebs containing no 
noradrenaline (and thus exhibiting only basal vascular tone) 
were challenged with bolus doses of timolol or carteolol, or 
saline control.
RESULTS
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Effects of 3-Adrenoceptor Antagonists on IOP
All eight drugs tested produced significant decreases 
in IOP. The graph of % Change in IOP from time zero as 
ordinate against time as abscissa (Fig.20) indicates that 
the effects of the 3-adrenoceptor antagonists timolol, 
oxprenolol. betaxolol and laevobunolol could be seen approx. 
10 min after bolus injection of 3nmol into the arterial 
perfusate. The further doses of 10 and 30nmol, administered 
20 and 40 min later, were given in an attempt to confirm 
dose-dependence of the IOP-lowering effect. The drug 
effects were compared with data from control perfusions in 
which vehicle was injected. The graph of % Change in IOP 
from time zero as ordinate against time as abscissa (Fig.21) 
indicates a similar result obtained with four further 3- 
adrenoceptor antagonists DHL, metoprolol. metipranolol and 
carteolol. Control eyes showed a slight but statistically 
significant tendency for IOP to rise: 2.2±1.9% (P<0.1, n=6 , 
60 min value vs. time zero value) over the period of 
perfusion. The falls in IOP mediated by each drug were 
expressed as percentages in order to obtain a more direct 
comparison of the effects of each drug, as initial IOP was 
rather variable. Timolol and oxprenolol yielded a
significantly greater drop in IOP than the other 3- 
antagonists (P<0.025).
When calculated in absolute terms, control eyes 
exhibited a statistically insignificant rise in IOP of
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0.2±0.2mmHg (n=6). The corresponding significant absolute 
fall in IOP in terms of mmHg pressure in response to 3. 10 
and 30nmol bolus injections of the 3-adrenoceptor 
antagonists was as follows in Table 3:
3-Adrenoceptor 
Antagonist
n Fall in IOP 
(mmHg)
P
Betsxolol 9 0.4+0 .1 <0 .01
Laevobunolol 9 0.4+0.1 <0 .005
Oxprenolol 10 0.6+0 .1 <0 .005
Timolol -i i O.7±0 .1 <0.005
DHL 11 0.6+0.1 <0 .005
Hetoprolol H 0.6+0.1 <0.005
Met ipra.no lol 10 0.5+0 .1 <0 .005
Oartsolo1 9 0.6+0 .1 <0 .005
Table 3. Fall in IOP in response to 6-antagonists, 60
min after bolus injections of 3, 10 and 30nmol of 
drug. Values given are meanis.e.m. P represents 
significance of difference between 60 min and time 
zero results as indicated by unpaired Student’s 
t-test.
Arterial perfusion pressure of 29.5±0.5mmHg (n=80) was 
unaltered by any of the 3-adrenoceptor antagonists tested 
under these conditions of low vascular tone.
Effect of Acetazolamide on IOP
A bolus injection of 0.3umol acetazolamide produced a 
fall in IOP within 15 min (Fig.22). Again, further doses of 
1 and 3umol were given in an attempt to test dose dependence
IN
TR
AO
CU
LA
R 
PR
ES
S,
 
(p
er
ce
nt
)
83
2 -
2 -
- 4 -
-6
- 2 0  - 1 0 0 10 20 30 40 50 60
TIME (m in)
% Change in TOP vs. Time.
Vertical Bar shovs s.e.m.
Saline Control o o Acetazolamide 0-
84
of the response. The drug effects were compared with 
control perfusions in which saline was injected. Control 
eyes exhibited a slight tendency for IOP to rise over 60 min 
of perfusion. Acetazolamide (0.3. 1 and 3umol) produced a 
small fall in IOP: 3.8±1.0% (P<0.005, n=8 .) . corresponding to 
a significant absolute fall in IOP: 0.4±0.1mmHg (P<0.005, 
n=8 ) .
Effect of Dopamine Agonist FPL 65879AA on IOP
The specific DA2 agonist FPL 65879AA, in bolus doses 
from 30nmol to 30umol. was found to have no significant 
effect upon IOP in comparison with corresponding injections 
of saline control.
Single Dose Timolol: IOP-Time Curve
A single bolus injection of lOnmol timolol yielded a 
sustained drop in IOP. falling to a plateau after a period 
of 50 min. which persisted over the 100 min of perfusion, as 
seen in Fig.23. The dose of timolol utilised yielded a 
significant, total drop in IOP of 10.4±1 .2% (P<0.005, n=6), 
measured as the difference between the initial IOP at time 
zero (drug injection) and the new IOP after development of 
the IOP plateau. 100 min after drug injection. This
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corresponded to a significant absolute drop in IOP of 
1.0±0.3mmHg (P<0.005. n=6 ) over the 100 min of perfusion. 
Control eyes injected with saline in this case exhibited a 
small but statistically insignificant drop in IOP of 
0.1±0.1mrnHg in=9).
Log Dose-Response Curves for IOP Effects of Timolol and
Carteolol
Experiments were performed as in procedure 4 with a 
single bolus dose of timolol, however in this case the drop 
in IOP mediated by a variety of doses of timolol and 
carteolol were ascertained. The results are shown in table
4.
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Dr uy B o 1 u s ij o —■ e 
nmo j.)
Total Drop in IOP 
(maiHg)
P
I undo I 0 . 0 3 6 0.2+0.1 n . s.
f! n 0 . 3+0.1 < 0 . 0 5
■* 0 . 4+0.1 (0 .01
1.0+0 .2 (n nnR
10 .0 £ 1.0+0.1 < 0 .005
30 . 0 h 1.1+0 .2 i n n n r
uarteolol n Q3 b 0.2+0 .1 n . 'B.
0 . 3 n 0.3+0 .2 n. s .
1.0 C 0,4±0.1 < 0 .01
3 .0 f- 0.5+0 . 2 •( n n 2 5
10 .0 c 0.7+0.1 (0 .005
3 U . U h 0.7+0 . 2 < U . U U D
Table 4 . Drug , bolus dose and total drop in IOP. Values
given are meanis.e.m. P represents significant 
difference between IOP at time zero and IOP at
100 min as indicated by unpaired Student's t-test.
Plotting the data in table 4 as the total drop in IOP 
as ordinate against log^Q (number of moles of drug injected
as bolus) as abscissa yields the log dose-response curves
for the IOP effects of timolol and carteolol as seen in
Fig.24. These log dose-response curves indicate a dose-
dependence of the pressure lowering effect of each drug,
with a maximum effect seen at 30nmol bolus dose approx. and 
ED5Q of Inmol approx., for both. Carteolol. however,
appears to be less efficacious as an ocular hypotensive 
agent than timolol upon the bovine perfused eye, yielding a 
maximum drop in IOP of 0.7±0.1mmHg (n=5). as opposed to the 
drop of l.l±0.1mmHg (n=6) obtained with timolol.
It appears from these log dose-response curves that the 
potency ratio of carteolol to timolol as ocular hypotensive
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agents is approx. unity when administered to the bovine 
perfused eye preparation.
Effect of Atriopeptin (AP) on IOP
The effect of AP (rat: fragment 1-27) upon IOP (Fig.25) 
could be seen approx. 15 min after bolus injection of 
lOpmol. A further dose of 50pmol was given 40 min later. 
Drug effects were compared with data from control 
perfusions. AP (10 and SOpmol) produced a significant 
reduction in IOP of 9.2±2.0% (P<0.005, n=9), corresponding 
to a significant absolute drop in IOP of 0.9±0.2mmHg 
(P<0.005, n=9). Arterial perfusion pressure was unaltered 
by AP under these conditions of low vascular tone.
Effect of AP on Ciliary Artery Perfusion
Vascular tone was significantly increased by 
36.5±2.9mmHg (P<0.005. n=87) on addition of noradrenaline 
bitartrate at 10~^ M to the perfusate reservoir. Perfusion 
of noradrenaline resulted in a rapid and continual 
fluctuation in IOP. which effectively nullified 
equilibration of IOP, thus rendering it impractical to 
conduct further investigation of the effects of drugs on 
IOP. For this reason, investigation of the vascular effects
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of drugs, and their IOP effects, were not undertaken 
simultaneously. Vascular relaxation to bolus doses of AP 
(10, 30 and lOOpmol) in the presence of noradrenaline was 
negligible, being similar to that produced by equivalent 
bolus injections of saline. Out of 10 such 
experiments, a small reduction in arterial 'perfusion, 
pressure (approx. 10% of the induced tone) was seen in only 
3 eyes. Data from one such experiment! are shown in Fig.26.
i
This contrasts with the reproducible and significant 
dilatation of the ciliary vasculature under tonic 
constriction produced by bolus injections of 0.3 and 3nmol 
sodium azide.
Effects of Other Vasodilator Drugs on Ciliary Artery
Perfusion
Again, vascular tone was increased by the addition of 
noradrenaline to the perfusate reservoir at a concentration 
of 10~5 m. Data obtained in one such procedure with sodium 
azidejare shown in Fig.27. The percentage relaxation of the 
vascular tone induced by noradrenaline was calculated in 
response to each dose of drug. As can be seen in Fig.27, 
injections of saline in this preparation produced no effect 
whatsoever upon vascular tone. Full recovery of tone was 
allowed before injection of the next dose of drug. The 
results for sodium nitroprusside, sodium azide, cromakalim.
10pl
AP
Vehicle
Sodium
azide
1 0 - 4 MArterial
perfusion
pressure
20mmHg
Sodium
azide
10-3M10 min.
Fig.26. Effect of Atriopeptin upon Ciliary Artery 
Perfusion Pressure.
10nmol0.3nmol 3nmol
SODIUM AZIDEVEHICLE
10mm Hg
5 min
10_ 5 M NORADRENALINE PERFUSION
Fig.27. Effect of Sodium Azide upon Ciliary Artery 
Ferfusiun Pressure.
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pinacidil. verapamil and nifedipine are shown in Fig.28, 
where all the data has been assembled for ease of comparison 
of different drugs. For details of the magnitude and 
statistical significance of these responses, the same data
are shown in table 5 .
i
Vasodilator Bolus Dose 
(nmol)
n Relaxation 
of Total 
Vascular Tone 
Induced by 
Noradrenaline 
(Percent)
P
SNF 0 . 01 9 3.6+1.0 <0 .005
0 .03 9 1.3+0 .7 < 0.05
0. i 13 7.1+0.8 <0.005
U . 3 17 13.0+2.3 <0.005
1.0 18 33.8+6.5 <0.005
3 .0 13 39.0+4 . 5 <0 .005
10 .0 •7i 40.3+5.8 <0.005
3 0 .0 11 61.9+5.2 <0 .005
100 . 0 7 79.2+12 .3 <0 .005
300 0 4 76.3+7 .1 <0 . 005
1000 .0 4 90.9 +  3 . 9 (C .005
3 0 0 0 . 0 4 88.3+7.5 <0 .005
Sodium Aside 0 .01 7 1.9+0.6 <0 .01
0 .03 9 9.1+3 . 2 <0 .025
0.1 12 22.1+6 .5 <0 .005
0 .3 23 27.3+5.2 < 0 .005
1.0 13 3 9.9+8 .4 <0 . 005
3 .0 23 49.4 + 5 .3 <0 .005
10 .0 21 65.6+7.8 <0.005
30 .0 20 62.3+10.1 <0 .005
100 .0 5 71.4+7 .8 <0 .005
300 .0 4 81.2+11.7 <0 .005
1000.0 4 82.5+5.2 <0 .005
Oromakalim
(ERL 34915) 0.3 6 8.2+1.5 <0 .005
1.0 6 11.3+3:3. <0 .01
3 .0 6 25.1+8 .2 <0.025
10 .0 14 56.4 + 3 .6 <0 .005
30 .0 11 6 3.1±7.2 <0 .005
Pinacidil 0.1 12 0.6+0.5 n . s .
0 . 3 12 1.0+0 .4 <0 .025
1.0 12 5.2±3 . 2 n . s .
3 0 12 9.1+3 .2 <0 .01
10 .0 12 35.1+7.5 < 0 . 0 0 5
30 .0 10 55.8+8.4 < 0 . 0 0 5
100 .0 13 70 1+9 7 (0.005
3QQ .0 14 7 5’2±iu . 4 <0 .005
1000 .0 13 98.0+11.0 <0.005
300Q . n 4 93 . 7+0 . 9 , <0 .005
Table 5 Continued/
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Verapamil 0.1 
0 .3 
1.0 
3 .0 
10 .0 
30 .0
6
7
n
9
li
12.3+1.0 
15.4+2 .8 
35.4+6.2 
36.4 + 3.'d 
44.1+3.2 
51.3+6.2
< 0 . 0 0 5 
<0 .005 
<0 .005 
<0 .005
< 0 . 0 0 5 
<0 .005
>T , 4 — J —it 0 .01 n 4.6+1.8 <0 .025
0 .03 ±L 13.3+3.6 <; 0 .005
0 .1 11 23.6+5.6 <0 .005
0 .3 10 29.7±5.7 <0 .005
1.0 *7 36.7+4.6 <0 .005
3 .0 *7 44.1+6.7 <0 .005
10 .0 u 51.3+10.1 <0 .005
30 .0 9 56 4+9.2 (0 .005
Table 5 . Effects of vasodilator drugs on ciliary artery 
perfusion pressure in the presence of
noradrenaline (1Q-  ^M ) . Values given are 
meanfs.e.ra. P represents significant difference 
betveen relaxation in response to drug and control 
as indicated by unpaired Student's t-test.
The vasodilators tested all produced substantial and 
reproducible vasodilatation over the dose range O.lnmol to 
30nmo 1. ! Addendum I
A maximum of seven injections o f drug per eye were given, as each 
individual eye remained viable for no more than 2 to 3h.
IOP Effects of Other Vasodilator Drugs
The dose-response relationship was examined in detail 
for the effect upon IOP of sodium azide, SNP and pinacidil. 
The data are shown graphically in Fig.29. and the details 
are given in table 6 .
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V a s 0 u i 1 a t- u r Bolus Dose 
(nmol)
n Drop in IGF 
(mrnHg)
11
P
SHF 0 .3 6 n c +r, i 0 . D x u .x <0 .005J 0.9±0.2 <0.005
10 .0 1U 1.1+0.3 <0 .005
1Q 0 . 0 ps 2.0±0.3 <0.005
1000.0 n 2 + ft O <0 .005
Sodium Azide 0 .01 7 0,4±0 .1 <0 .01
0 i 3 0.6+0.1 <0 .00 5
0 3 c 1.3 + 0 .2 <0 .005
i. u K 2.0+0. 4 < 0 . 0 0 5
10 .0 7 2.2±Q.3 < 0 . 0 0 5
Pinacidil 3 . 0 6 0.4+0 . 2 <0 .05
10 .0 h 1 . 0+0.3 <0 .01
100 .0 9 1.0±0 .2 <0 .005
IQ00 .0 Q -* p. 4- a •--L. . J X U . J <0 .005
J  1J 1j  U . ij £u 1 .5+0 . 2 <0 .005
Table 6 . Effects of vasodilator drugs upon IOP. Values 
given are meanis.e.i. P represents significant 
difference between IOP at time zero and IOP at 
100 min as indicated by unpaired Student's t-test.
The log dose-response curves for the IOP effect of
these drugs indicate a dose dependence of the pressure 
lowering effect of each drug, with maximum doses and EDs q 's
as listed in table 7.
v d'sUUiid 1' i "la x i iu u m i1 j ir'
Reduc ing Dose 
(nxuc 1)
ED5 0 (nmol)
SNF 1000 10
Sodium Aside 10 0 . 3
Pinacidil 1000 100
Table 7. Vasodilator, maximum IOP reducing dose and ED5 0
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Examining the maximum response of each drug, pinacidil 
appears to be significantly less efficacious than either SNP 
or sodium azide.
Investigation of EDRF Production by Uveal Vascular
Endothelium
Table 8 indicates the vascular relaxation response to 
tone induced by the presence of noradrenaline, mediated by 
bolus doses of ACh. in the presence and absence of L-NOARG. 
It can be seen that L-NOARG diminishes significantly the 
vasorelaxant effect of ACh.
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Bolus Dose 
ACh (nmol)
Ti Reis.:-: at ion 
of Total 
Vascular Tone 
Induced by 
Noradrena1 ins 
(Percent)
Relaxation 
of Total 
Vascular Tone 
Induced by 
Noradrenaline 
(Percent - 
in presence 
of L-NOARG)
P
0.03 1 0 3 .6 + 2 .5 3,6±2 .4 n . s .
0 . 1 1 0 1 0 .8+3.0 4.3+4 .0 <0 .05
0 .3 1 0 11.4+4 .8 4.9+1.2 <0 .025
1 . 0 1 0 16.9+5 . 9 4.6+3 .3 <0 .005
3 .0 1 0 21.9+6.7 3.7±5 .2 <0 . 0 1
1 0 . u r.O 23.3+6 . 4 9.1+5.5 <0 .005
30 .0 3 22.6+7.1 8 .9+5 .3 < 0 . 0 1
1 0 0 .0 6 28.0±7.5 9 .8 + 5 . 4 <0 .005
Table 8 . Effect of ACh on ciliary artery perfusion pressure
in presence of noradrenaline (1 0 -  ^M) and
noradrenaline plus L-NOARG (3X10-  ^M ) . Values 
given are meanis.e.m. P represents significant 
difference between relaxation in response to ACh 
in eyes perfused with noradrenaline, before and 
after addition of L-HOARG to perfusate, as 
indicated by paired Student's t-test.
Ciliary Cyclic GMP Determinations
Table 9, of drug treatment and ciliary cyclic GMP 
indicates that sodium azide yielded a significant increase 
in ciliary cyclic GMP compared with saline treated control, 
AP also yielded a significant increase in ciliary cyclic GMP 
compared with saline treated control, although the increase 
was smaller in this case.
100
Drug Treatment n Ciliary Cyclic GMP 
fmol/mg protein
P
Saline Control h 126.8+16.8
Sodium Aside vlunmolj 6 232.9127.4 <0 .005
AP (O.lnmol) 5 209.2122.1 < 0 . 01
Table S. Effects of drugs on ciliary cyclic GMP levels.
P represents significance of difference between 
control and drug treated groups as indicated by 
unpaired Student’s t-test.
Drug Effects on Vascular Flow Using 
Radiolabelled Microspheres
Of all the structures within the eye which were 
dissected out. significant quantities of spheres were found 
only within the iris, ciliary body and choroid/sclera. 
Activity within the choroid/sclera was assumed to be due to 
the entrapment of spheres in the choroid, as the sclera is 
relatively avascular. Activity found within the cornea, 
retina and extra-ocular muscle was negligible, and no 
activity was detected in the vitreous or aqueous. The 
introduction of noradrenaline at 10“^ M into the perfusate 
caused a significant increase in arterial perfusion pressure 
from 34.0±5.1mmHg to 71.0±7.4mmHg (P<0.005, n=45), and a 
significant decrease in the number of spheres entering the 
ocular circulation, from 1118±120 (24.8%±2.7%), n=20, to 
819±138 (18.2%±3.1%) , n=21. P<0.05. The vast majority of 
the remaining spheres were found in the perfusate tubing
101
proximal to the eye, and in the cannula. A very small 
proportion (0.8±0.2%. n=45) were found in the effluent 
perfusate leaving the eyes through the venous outflow. The 
observed activity for each tissue and treatment group is 
shown in Fig.30. The data indicate that timolol or 
carteolol at 30nmol bolus dose do not significantly increase 
the numbers of spheres entrapped in the iris, ciliary body 
or choroid, as compared with control. Bolus doses of 
300nmol SNP or verapamil elicited significant increases in 
the numbers of spheres entrapped in the iris, ciliary body 
and choroid in the noradrenaline perfused group (P<0.01, 
Mann-Whitney test), and in separate experiments, significant 
reduction in arterial perfusion pressure of 29.8±4.3mmHg 
(mean±s.e,m., P<0.05. n=10). The observed activity for each 
tissue in each treatment group in the absence of 
noradrenaline is shown in Fig.31. Timolol at 30nmol bolus 
dose was found to reduce the numbers of spheres entrapped in 
the choroid (P<0.01, Mann-Whitney test). When administered 
at 300nmol bolus dose, a significant reduction in the 
numbers of spheres was observed in the iris (P<0.01. Mann- 
Whitney test) . Carteolol at 30nmol bolus dose yielded a 
significant reduction in the numbers of spheres entrapped in 
the iris, ciliary body and choroid (P<0.01, Mann-Whitney 
test). Carteolol at 30nmol bolus dose, however yielded a 
small but significant increase in arterial perfusion 
pressure of 8 . 22±2 . 33rnmHg (meanis.e.m. . P<0.025, n=10, 
student's t-test) in the non-noradrenalme perfused eyes.
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Fig.30. Radioactivity in Various Ocular Tissues following 
Perfusion vith Labelled Microspheres. Results 
Indicated are Means of 5 experiments. Vertical 
Bar shovs s.e.m. Prior to each experiment, 
Noradrenaline vas incorporated into Krebs solution
at 10~5 M concentration.
&P(0.01. Differences from control as indicated 
by Mann-Vhitney Test.
C
or
re
ct
ed
 
M
ea
n 
d
p
n
i/
gt
is
su
e
103
Control
n=5
Timolol
30nmol
n=5
Timolol
300nmol
n=5
□  Iris 
Ciliary Body
Choroid
8000-r
7 0 0 0 -
6 0 0 0 -
5 0 0 0 -
4 0 0 0 -
3 0 0 0 -
2000-
1000 -
Carteolol
30nmol
n=5
Fig.31 . Radioactivity in Various Ocular Tissues following 
Perfusion with Labelled Microspheres. Results 
Indicated are Means of 5 experiments. Vertical 
Bar shows s .e .m .
*P<0.01. Differences from control as indicated 
by Mann-Vhitney Test.
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lasting for approximately 1 min.
DISCUSSION
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The Isolated Arterially Perfused Eye
Studies of ocular physiology utilising the isolated 
perfused eye preparation are scarce in the literature. 
However, results obtained via experimentation upon perfused 
eye preparations from several species have been reported. 
Facility of outflow in the bovine (Erickson-Lamy et al..
1988) and human CErickson-Lamy et al.. 1991; Liang et a l ..
1992) perfused anterior segment has been measured. Macri 
and Cevario (1973), using the feline eye. conducted an 
investigation into the "induction" of aqueous humour 
formation using the cholinergic drugs acetylcholine and 
eserine. In the feline perfused eye, some drugs produce the 
same effects as in the human, although results with timolol 
are conflicting (Helal et a 1.. 1979: Macri et al .. 1980). 
Arachidonic acid is reported to decrease aqueous humour 
secretion in this preparation (van Alphen & Macri, 1981). 
Kodama et a 1. (1985) employing the rabbit perfused eye, 
studied the effects of a selection of ocular hypotensive 
drugs upon aqueous humour formation, which was found to be 
significantly reduced by timolol, adrenaline and (at high 
concentration) acetazolamide. The bovine perfused eye has 
also been described, in a study of glutathione depletion and 
oxidative stress (Kishida et al.. 1985) and in a preliminary 
communication on drug effects on IOP (Wilson, 1988).
Although they recommended the bovine perfused eye for 
biochemical studies. Kishida et al. judged this preparation
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to be unsuitable for the investigation of aqueous humour
dynamics. However, these authors commenced perfusion within
1 to 2h post mortem, which may explain their dissatisfaction
with their results. The present results indicate that any
delay in the commencement of perfusion beyond lh after
slaughter considerably reduces the probability of achieving
a stable IOP. However, no correlation was found between
success rate and postmortem time when not exceeding 50 min.
In the present study, steady state IOP achieved in the
isolated perfused bovine eye lies in the range 7 to 11 mmHg.
In this preparation, the episcleral venous pressure is
probably not much above zero, since the vortex veins are
cut. Assuming that all the episcleral veins drain into the
vortex veins, these values are equivalent to a range of 15.5
to 21.5 mmHg in vivo, if we are to assume an episcleral
venous pressure of 9 rnmHg in the living animal. This is in
reasonable agreement with the report by Woelfel et al.
(1964) that in the calf. IOP in vivo is 16.4±1.6 mmHg.
Cannulation of the anterior chamber with a 23 gauge steel
needle, and connection to a water manometer was chosen as
the method of measurement of IOP in this preparation since
this allowed for continual measurement of IOP over the
period of experimentation. In addition, the relatively
small changes in IOP which occurred could be very accurately
and reproducibly determined, since even a small change of
IOP in mmHg pressure shows as a considerably greater 
corresponding change in mrrtf^ O pressure (there being approx.
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13.6 mmH20 to every ImmHg). Tonometry does not guarantee as 
reproducible results as the anterior chamber cannulation 
method. Electronic measurement and recording might well 
involve baseline drift in excess of ImmHg over a 1 to 2h 
period, and further would probably disturb the equilibration 
of the preparation at each attempt to take a reading. 
Additionally, tonometry would be less sensitive to the small 
changes in IOP being measured.
The constant flow method of perfusion was adopted as 
the preferred method. Earlier work with the bovine perfused 
eye by Wilson (1988) included a procedure whereby bovine eye 
preparations were perfused via a constant pressure method, 
while flow rate was monitored electronically. However, it 
was found that this method of perfusion resulted in 
significantly lower starting IOP, and a rather lower 
proportion of eyes whose IOP remained stable during the pre­
drug part of the experiment.
After arterial cannulation. some eyes were rejected due 
to a failure to achieve adequate perfusion. Adequate 
perfusion was judged on the basis of the following criteria: 
that there should be at least two vortex veins flowing, and 
that at no point during the initial phase of perfusion 
should perfusion pressure rise above 100 mmHg.
Additionally, in the pre-drug part of the experiment, 
perfusion pressure and IOP should equilibrate between 20 and 
60 mmHg, and 7 and 11 mmHg pressure respectively, within a 
period of 90 min after commencement of perfusion. The
Addendum II
Control eyes in some experiments showed an acceptable small (but 
statistically significant) tendency for IOP to rise (Figs. 20, 21, 22 & 25), but not 
in others (Fig.23). This was probably due to a progressive slight increase in 
the permeability o f the blood-aqueous barrier over the course o f perfusion, in 
some eyes.
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overall rejection rate based upon these criteria was 34%, 
however the rejection rate after drug injection was found to 
be only 6%.
Wilson (1988), describing the constant pressure 
perfusion of the bovine eye, inferred that the addition of 
dextran and albumin to the Krebs physiological saline 
solution was beneficial towards maintaining the integrity of 
the blood-aqueous barrier. However, it has been found 
subsequently that provision of oncotic pressure in the 
perfusion fluid does not significantly protect the barrier, 
during the course of the perfusion procedure (Wilson et a 1.. 
1993). No provision was made therefore for oncotic pressure 
in the perfusate: the immediate benefit of this being the 
absence of albumin in the perfusate and therefore the 
negation of any problems of drugs injected into the 
perfusate binding to the albumin, and thus being unavailable 
for the mediation of a pharmacological effect. The ability 
of the preparation to yield reproducible results in the 
absence of oncotic pressure was not found to be 
significantly compromised. Further, it has been shown that 
the provision of oncotic pressure in the perfusate via the 
addition of dextran and albumin does not significantly 
protect the blood aqueous barrier for the purposes of the 
study of intraocular pressure. Wilson et a l . (1993) report
that a correlation exists between rising IOP and leakage of 
albumin into the chamber.
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In an effort to determine that the tissues of the
isolated perfused eye are metabolically active, an estimate
was made of C>2 consumption and CO2 production by perfused
fresh eyes, and also by perfused dead eyes (Wilson et al..
1993). Fresh bovine perfused eyes showed a significant net 
consumption of O2 and production of CO2 when compared with
eyes which had been placed in cold storage for 24h prior to 
perfusion. By varying the perfusion rate through the 
ciliary artery it is possible correspondingly to increase 
the perfusion pressure. By allowing IOP to stabilise at 
each step, it has been shown that an 80% increase in 
perfusion pressure results in less than a 9% increase in IOP 
(Wilson et a l .. 1993). This clearly provides evidence that 
the production of aqueous humour in the bovine perfused eye
is an active secretory process, not one of passive
ultrafiltration or leakage.
The advantages offered by this preparation as a model 
for the study of aqueous humour dynamics lie in the 
convenience of an easily obtained and inexpensive tissue, 
whose use does not require the killing of animals purely for 
experimental purposes, an issue over which public concern 
has been mounting (Fox, 1984).
Although drugs are not usually delivered via the 
arterial route in vivo, in the perfused eye the intra- 
arterial route of drug administration affords a much more 
accurate estimate of the speed of drug response than does 
the topical route which is conventionally used. If a known
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concentration of drug is perfused (instead of injecting 
bolus doses) then the drug concentration in the vicinity of 
the target cells will be accurately known. This avoids the 
very large losses of drug which can occur during corneal and 
conjunctival absorption, and due to diffusion through other 
ocular tissues and fluids. This preparation lends itself to 
studies of drug mechanisms on aqueous humour dynamics 
especially where the drug may have effects on the blood 
vessels or on the blood-aqueous barrier.
IOP Effects of the 0-Adrenoceptor Antagonists
Results obtained with the 3-adrenoceptor antagonists 
confirm that the standard 3-adrenoceptor antagonists used in 
the treatment of COAG are able to lower IOP in this 
preparation, in a reproducible and dose-dependent manner. 
However, it was impractical to test numerous drugs at 
various doses, up to those doses producing maximal 
responses, due to the great volume of work which this would 
incur. Hence it is not possible to ascribe accurately any 
potency differences between them in their pressure lowering 
effects. It would appear, however, that timolol, oxprenolol 
and metoprolol are the most potent, whilst betaxolol and 
laevobunolol are the least. Carteolol appears to be almost 
as potent as timolol, a little surprising since results to 
clinical trials indicate that carteolol at 1% is about
Ill
equipotent with timolol at 0.25% (Horie et a l .. 1982). On 
the other hand, betaxolol in the clinical situation is 
reportedly less potent than timolol (Allen et a 1.. 1986; 
Allen & Epstein, 1986).
In order to obtain more useful data concerning the 
ocular hypotensive effect of the 0-adrenoceptor antagonists, 
a modified experimental approach was initiated. It may be 
observed from the % Change in IOP - Time curves obtained 
with the B-adrenoceptor antagonists (Figs.19 & 20) that the 
total fall in IOP elicited by each drug at the given dosages 
does not appear to be complete: rather, what is shown is the 
first part of the fall in IOP. Were the time axis to be 
extended further, then, based on the experimental results, 
one would expect to see a further drop in pressure. The 
pressure drop had commenced approx. 10 min after injection 
of the initial bolus dose of drug, and showed little sign of 
abating before injection of the following dose. When the 
effects of injecting a single bolus dose of timolol were 
monitored for a longer time (Fig.22). the IOP was seen to 
stabilise after approx. 50 min. By 100 min the plateau on 
the IOP-Time curve is completely formed. By repeating the 
procedure with various bolus doses of timolol, significantly 
different total drops in IOP can be seen in each case, 
facilitating the construction of log dose-response curves, 
as seen for timolol and carteolol (Fig.24).
Clinically, when a dose of B-adrenoceptor antagonist is 
given topically, IOP starts to fall but eventually forms a
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stable lower IOP. This is sustained typically for a period 
of approx. 12h, whereupon it will start to rise once again, 
unless a further dose of drug is given to keep it at its 
lower level. The situation clinically, however, differs 
from the experimental situation in that the drug, given 
topically, and at very high concentration (0.006 to 0.06M 
approx.) sets up a relatively large depot in the inferior 
fornix, and absorption leads to the establishment of a much 
smaller depot in the conjunctiva, cornea, iris and ciliary 
body (Maurice & Mishima. 1984). The drop in IOP is 
relatively great, of the order of 5 to lOmmHg. as compared 
with the perfused eye preparation. The fact that only 
relatively small drops in IOP were seen in the present 
method was most probably due to the fact that episcleral 
venous pressure is probably equal to zero in this 
preparation, as previously discussed, and the drugs were 
given arterially as a bolus injection, so that within a 
short space of time the majority of the drug was washed out 
of the preparation. Further, species differences between 
the bovine and human eye may play a part in the relatively 
modest response to the 3-adrenoceptor antagonists, as well 
as the fact that the bovine eyes may have been compromised 
by trauma, anoxia and lack of normal nutrition.
There is much evidence that the IOP lowering effect of 
the 3-adrenoceptor antagonists is not mediated by binding to 
a classical 3-adrenoceptor, as detailed previously. The 
ability of the 3-adrenoceptor antagonists to reduce IOP in
Addendum III
It is, however, not known whether all neuronal noradrenaline is 
depleted in nerves associated with the iris/ciliary body of the bovine eye, even , 
after isolation for periods of 2 to 3h.
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the perfused eye implies that their effect is not dependent 
upon intact sympathetic innervation, nor upon the presence 
of circulating catecholamines. Since an antagonist does not 
generally produce any effect in the absence of its agonist, 
this provides further evidence that the ocular hypotensive 
effect of the 3-adrenoceptor antagonists is mediated via 
some effect other than antagonism of a classical 3- 
adrenoceptor.
It is generally accepted that stimulation of adenylate 
cyclase via a G protein is the post-receptor mechanism of 
the 3-adrenoceptor. However. Shahidullah and Wilson (1992) 
reported that bolus injection of the 3-adrenoceptor agonist 
terbutaline did not mediate an increase in ciliary cyclic 
AMP concentration, but did yield a significant decrease in 
the rate of secretion of aqueous in the bovine perfused eye 
preparation. In addition, forskolin was seen to mediate an 
increase in ciliary cyclic AMP concentration, but had no 
effect upon aqueous secretion. This, and other evidence 
(reviewed by Lotti et al., 1984) casts further doubt upon 
whether conventional 3-adrenoceptors are involved in the 
ocular hypotensive effect of timolol. For example.
Vareilles et a l . (1977) noted that in rabbits a 500 times
greater concentration of timolol was required in order to 
reduce water load induced elevation of IOP. than that 
required to antagonise the inhibitory effects of 
isoprenaline in the same assay. Further, the concentrations 
of timolol in the aqueous humour following instillation of
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0.5% solution in rabbits were approx. 1000 times that 
required to antagonise 3-adrenoceptors in other tissues. 
Bonomi et a l . (1979) observed that the effectiveness of
various 3-adrenoceptor antagonists in lowering IOP in ocular 
hypertensive rabbits did not correlate with their peripheral 
3 blocking potencies judged by inhibition of isoprenaline 
induced tachycardia. Similarly, Sears (1979) reported that 
preliminary studies indicate that the 3-adrenergic binding 
and blocking potencies of propranolol, timolol and pindolol 
do not appear to parallel their ocular hypotensive effects. 
More recently. Schmitt et a l . (1981b) found little 
relationship between the ability of timolol, propranolol, 
oxprenolol and practolol to antagonise the ocular 
hypotensive effect of isoprenaline in water-loaded rabbits. 
Additionally, the ability of these 3-adrenoceptor 
antagonists administered topically to antagonise 
isoprena1ine-induced elevation of cyclic AMP in the aqueous 
humour, was not correlated with their ocular hypotensive 
act ivity.
IOP Effects of Inhibitors of Carbonic Anhydrase
As a means of validating the bovine perfused eye as a 
preparation for studying drugs which lower IOP. the carbonic 
anhydrase inhibitor acetazolamide was tested. This compound 
is well documented as an ocular hypotensive agent in the
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human eye and that of several animal species (Becker, 1954, 
1955; Friedland & Maren, 1984). However, in the present 
preparation, the results with acetazolamide indicate that a 
very high concentration is required to produce only a 
relatively modest reduction in pressure. On the face of it 
this would suggest that the dependence of aqueous humour 
production on the active secretion of bicarbonate ion is 
probably of minor importance in the bovine eye. This 
result, however, contrasts with the findings of Wilson et 
al. (1993), that the new carbonic anhydrase inhibitor MK-927 
will reduce both aqueous secretion rate in the bovine 
perfused eye. over the range 1 to lOOnmol bolus dose. MK- 
927, however, has considerably higher lipid solubility than 
acetazolamide. Therefore it may be that MK-927 gains access 
more readily than acetazolamide to bovine ciliary carbonic 
anhydrase.
Involvement of Dopamine Receptors upon IOP
The DA2 agonists bromocriptine, lergotrile and
pergolide are known to lower IOP in the rabbit and monkey 
eye (Potter & Burke. 1983), and human eye (Geyer et al., 
1987). The Fisons DA2 agonist, FPL 65879AA. however, was
found to be without effect over a relatively large dose 
range, up to and including some high doses. This is perhaps 
not entirely surprising, however since the site of action of
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dopamine DA2 agonists when acting as ocular hypotensive 
agents may well be central (Potter & Burke. 1982). The
perfused eye preparation has no capacity for responding to a 
substance which elicits its effects in this way. No BA2
receptors have been found in the ciliary tissue or elsewhere 
in the ocular structures of the rabbit (Mallorga & Sugrue, 
1987).
Effect of AP on IOP
AP is observed to decrease IOP in rabbits (Sugrue & 
Viader. 1986; Steardo & Nathanson. 1987; Nathanson. 1987), 
Bianchi et a l . (1986) postulated an inhibition of adenylate
cyclase as the mechanism by which AP achieves this effect. 
Nathanson (1987). Mittag et a l . (1987). Korenfeld and Becker
(1989) and Fawcett and Wilson (1989) suggested that 
activation of guanylate cyclase is responsible. Nathanson 
demonstrated that AP receptors, coupled to the activation of 
guanylate cyclase are present in the rabbit ciliary 
processes. Further, it was shown that an intravitreal 
injection of AP into rabbits resulted in a marked decrease 
in IOP in the ipsilateral eye persisting for more than 48h, 
with a smaller reduction in IOP in the contralateral eye. 
Mittag et a l . investigated the effect of a synthetic AP upon 
both ciliary guanylate cyclase and ciliary adenylate cyclase 
activity, in the albino rabbit eye. This group concluded
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that ciliary guanylate cyclase is partially stimulated by 
intravitreal injection of AP (2 to 4ug per eye), and the 
concomitant rise in ciliary cyclic GMP leads to a 
stimulation of ciliary adenylate cyclase. Further, a 
significant reduction in IOP was observed, lasting for a 
period of 40h. Korenfeld and Becker reported a significant 
decrease in IOP following intravitreal injection of AP into 
rabbits, with a concomitant increase in cyclic GMP in iris- 
ciliary body preparations. This group also presented 
evidence that after intravitreal injection of AP there is a 
decrease in aqueous secretion, associated with the decrease 
in IOP. Fawcett and Wilson reported that cyclic GMP in 
isolated bovine ciliary processes increased 5-fold in 
response to incubation with A P . The rise occurred within 
90s of addition of AP and reportedly persisted beyond 12 
min. This was confirmed in the present work by the
observation of a significant increase in cyclic GMP in
ciliary processes taken from perfused eyes following 
treatment with A P . In all cases, however, the in vitro work 
cited involved ciliary tissue which was composed of vascular 
as well as secretory cells. Since AP is known to increase 
cyclic GMP in vascular tissue (Winquist. 1985). these 
observations may just have been a reflection of the ciliary
blood vessels' response to A P . The present results show
that AP lowers IOP in the perfused eye preparation. The 
time course reported by Fawcett and Wilson (1989) for the 
rise in ciliary cyclic GMP is compatible with the observed
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decrease in IOP occurring approx. 15 min after the first 
holus injection of AP (Fig.25).
Vascular Effects of AP
It is clear from several observations reported in the 
literature (Nilsson & Bill. 1984; Nilsson et al.. 1985; 
Chiou & Yan. 1986) that a uveal vasodilatation is often 
accompanied by a change in IOP. Receptors specific for AP 
have been reported in rabbit ciliary body (Bianchi et al.. 
1986). It was important to determine the effect of AP upon 
the ciliary vasculature since AP is reported as relaxing 
resistance arteries in various vascular beds, for example, 
in kidney, pituitary gland and intestine (Napier et al.. 
1984), brain (Contin & Genest. 1985) and adrenal gland 
(Gibson et a 1.. 1986). This effect occurs via the 
activation of guanylate cyclase and hence a cyclic GMP 
dependent protein kinase, which leads to inhibition of 
calcium ion release from the sarcoplasmic reticulum of 
vascular smooth muscle (Murad. 1978, 1986). It has however 
been demonstrated in the present study that this is not in 
fact the case. The bolus dose of AP required to lower IOP 
lacks detectable vasodilator effects in the perfused eye 
preparation. By the same reasoning, the rise recorded in 
ciliary cyclic GMP is probably related to a decrease in
119
aqueous humour formation, rather than to a relaxation of the 
arterioles present in the ciliary tissue assayed.
Effects of Other Vasodilator Drugs
The results obtained with AP in this preparation were 
fundamentally significant, and led to the examination and 
comparison of the ocular and vascular effects of a number of 
other vasodilators on a similar basis. Since AP is known to 
increase ciliary cyclic GMP (Nathanson. 1987), other 
vasodilators which are also known to activate guanylate 
cyclase were studied, specifically, the nitrovasodilators 
sodium azide and SNP (drugs which reportedly also have 
ocular effects in vivo). Since sodium azide is also known 
to stimulate the release of EDRF from the endothelium of 
various blood vessels (Katsuki et a 1.. 1977). it was further 
decided to test the bovine uveal blood vessel endothelium 
for the production of EDRF. L-NOARG acts as an inhibitor of 
nitric oxide synthase, and thus reduces the synthesis and 
release of EDRF by the vascular endothelium in response to 
ACh. thereby reducing the effectiveness of ACh as a 
vasodilator. This was seen in the bovine perfused eye 
preparation (Table 8 ). On the basis of these experimental 
results, therefore, it appears that EDRF is indeed released 
by the endothelium of the uveal vasculature. Since EDRF 
mediates activation of a soluble guanylate cyclase, it may
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directly affect secretion from the ciliary epithelium.
Among the other vasodilators chosen for study was the 
ATP-sensitive potassium channel agonist pinacidil. Numerous 
reports in the literature indicate that this drug opens 
plasma-membrane K+ channels which respond to ATP, and in so 
doing mediates a decrease in intracellular free K+ . This in 
turn leads to an inhibition of release of Ca^+ from 
intracellular stores. Such reports include examples of 
vascular smooth muscle from several sources, for instance 
rabbit aorta (Gelband et a l .. 1988; Bray et al.. 1991), 
rabbit superior mesenteric artery (Meisheri et a 1.. 1991) 
and rat portal vein (Hamilton et al.. 1986; Hamilton & 
Weston. 1989; Hu et al.. 1990).
From the results obtained it is clear that sodium 
azide, SNP and pinacidil all possess the ability to lower 
IOP in a reproducible and dose-dependent manner in this 
preparation. The nitrovasodilators are more efficacious in 
this respect than the potassium channel agonist (Fig.29), a 
possible consequence of the different mechanism of action of 
this drug. The potency of sodium azide is approximately 
lOOx greater than that obtained with SNP, perhaps reflecting 
the dual mode of action of azide upon both guanylate cyclase 
and EDRF. Also, against a noradrenaline-induced vascular 
tone, the three vasodilators all yielded significant and 
dose-dependent relaxation (Fig.28). In this respect all 
three drugs appear equally efficacious. The order of 
potency for all three drugs is the same for both parameters.
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sodium azide being more potent than SNP. which in turn is 
more potent than pinacidil. Again, the greater potency of 
sodium azide than SNP may be a reflection of its dual mode 
of action upon both guanylate cyclase and release of EDRF 
(Murad, 1986). Although the range of potency is spread over 
three orders of magnitude for the ocular effect, however, it 
is spread over only one order of magnitude for the vascular 
effect.
If the log dose-response curves for the IOP effect
(Fig.29) and the log dose-response curves for the vascular
effect (Fig.28) are drawn together on a common set of axes,
an important result is seen (Fig.32). Comparing the effects
of pinacidil and SNP upon IOP and upon the vasculature, it 
can be seen that each drug exhibits an ED50 which does not
differ significantly for each parameter. Therefore it may
be suggested that the ocular effect of pinacidil and SNP
could be related to their vascular effects in this
preparation. However, when the effect of sodium azide upon
IOP is compared with its effect on the vasculature, some 30- 
fold difference is seen in the respective ED5Q values. The
data indicate that for sodium azide, as for AP, IOP 
reduction can be measured at doses below the threshold for 
vasodilation of the ciliary vascular bed. The direct assays 
of cyclic GMP show that in the ciliary tissue collected 
(which must consist mainly of ciliary epithelium), an 
increase in cyclic GMP occurs in response to the same dose 
of sodium azide or AP which lowered IOP. This provides good
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evidence that cyclic GMP is involved in this response, 
particularly since sodium azide and AP are known to affect 
synthesis of this nucleotide by different mechanisms: sodium 
azide by stimulation of a soluble guanylate cyclase (Murad 
et a 1. . 1978), and AP by stimulation of a particulate 
guanylate cyclase (Nathanson, 1988). The present results 
allow for the correlation, in one preparation, of data for 
sodium azide and AP-induced changes in all three parameters: 
IOP, vascular resistance and ciliary cyclic GMP content.
In summary, the data show that the four vasodilators 
investigated (including AP) all lower IOP in the perfused 
eye preparation. The data further suggest that, at least in 
the cases of AP and sodium azide, the ocular effects cannot 
be the result of a vascular action, and that cyclic GMP may 
operate as a second messenger in the ciliary epithelium.
The finding that sodium azide produces corresponding results 
to AP (unlike the other drugs tested) suggests that they are 
particularly efficacious with respect to their ability to 
lower IOP. There is no reason to expect that vasodilation 
per se should lower IOP when no change in perfusion pressure 
is evident. This has been emphasized by the finding in the 
bovine perfused eye that a large (80%) increase in perfusion 
pressure produces a very small (9%) increase in IOP (Wilson 
et al .. 1993). Hence it is quite likely that the other 
vasodilators tested (SNP and pinacidil) also lower IOP 
independently of their vascular relaxant effects. Since SNP 
is believed to stimulate a soluble guanylate cyclase
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(Katsuki et al.. 1977), it may well act by this mechanism In 
the ciliary epithelium also. The present results, however, 
suggest that it is less efficacious than sodium azide in 
this regard.
Vascular Flow Determinations Utilising Radiolabelled
Microspheres
There are several practical difficulties which require 
to be overcome when utilising labelled microspheres.
Firstly, it is essential to introduce sufficient spheres 
into the system under study in order that statistically 
significant changes in flow in response to a drug may be 
measured. Warren and Ledingham (1974) suggest introducing a 
minimum of 1000 to 5000 spheres, when dealing with a whole 
animal. It is important that the number of spheres infused 
in any experiment is sufficient to yield good counting 
conditions, even in the smallest organ counted, usually the 
spleen. Hales (1974) states that a minimum of 400 spheres 
is required to be trapped in a tissue in order to come 
within 95% confidence limits in calculation of mean 
activity. Utilising -^^^Ce-label led spheres, which emit 
highly energetic gamma rays, it was of course desirable to 
keep the numbers of spheres to a minimum. When dealing with 
the isolated perfused eye. however, it was felt that a
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minimum number of 400 spheres per structural component was 
necessary, in order to yield reliable data.
Another problem associated with the use of microspheres 
is the question of how to introduce the spheres into the 
system under study. The spheres are prepared as a 
suspension in saline, which must be agitated directly before 
use. Simple injection of this suspension, however, into the 
animal will result in the majority of the spheres being 
trapped in either the lumen of the syringe needle, or the 
needle connection (Hales, 1974). Thus very few spheres will 
successfully enter the system under study. It is necessary 
therefore to design an injection chamber whereby a 
suspension of spheres can be directly introduced into the 
flowing system. Several such designs have been utilised for 
in vivo studies, for example, the special glass vial 
(Rudolph & Heymann, 1967). the catheter (Sasaki & Wagner, 
1971). and the disposable plastic syringe connected to a 
length of catheter rather than a needle (Kaihara et a 1., 
1968). In the present study, however, it was considered 
most appropriate to utilise a two-way flow system, as 
previously related (Fig.19). This was because this design 
enabled spheres to be introduced into the perfusate without 
interruption of flow, an important consideration when 
dealing with an isolated organ perfused in vitro, when there 
is an inherent need for equilibration of the system. Any 
interruption to perfusate flow during sphere infusion could 
adversely affect the final results. Utilising this system
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it was found that sufficient spheres entered each eye, in a 
reproducible manner.
Selection of suitable sphere diameter is also crucial. 
If the spheres are too small then the majority will simply 
pass completely through the circulatory system under study; 
too few would actually be trapped in the tissue capillaries 
for attainment of reproducible results. If the spheres are 
too large, then few will enter the tissues under study, 
Henkind et al. (1979) quotes a range of diameters of the
uveal capillaries from 8 to 40um. Several workers, studying 
uveal circulation or total circulation in the eyes of cats, 
monkeys and rabbits (Aim & Bill. 1973: Oksala, 1988; Nilsson 
et al.. 1985) successfully utilised spheres of 15um 
diameter. 15um diameter spheres were therefore chosen in 
the present study of uveal perfusion in the isolated bovine 
eye. Such a diameter of microsphere is. however, probably 
too large to enable measurements of retinal flow to be made, 
as the retinal capillaries reportedly vary from 8 to 15um in 
diameter (Henkind et a 1.. 1979). But in this study uveal 
flow was of major interest, and the retinal artery was not 
cannulated. The fact that only negligible counts were found 
in the retina may reflect the lack of any branches leading 
from the long posterior ciliary arteries to the retinal 
circulation, distal to the point of cannulation, and 
negligible retinal supply from the choroid. As very few 
spheres were found in the effluent perfusate arising from 
the venous outflow through the vortex
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veins, it appears that a good choice of sphere diameter was
made. This was further confirmed by the significant and
reproducible sphere entrapment found in the uvea.
Investigation of Drug Effects on Vascular Flow
From the data obtained, when comparing control eyes 
perfused with Krebs containing noradrenaline with control 
eyes not perfused with noradrenaline, it is clear that the 
perfusion of noradrenaline alone significantly reduces 
entrapment of spheres in the iris, ciliary body and choroid. 
This, together with the observation that more spheres were 
found proximal to the eye in the noradrenaline perfused 
group, but no more in the perfusate effluent, indicates that 
noradrenaline mediates a constriction of the uveal blood 
vessels throughout the structures of the eye examined.
From data obtained with drugs where noradrenaline was 
perfused, it is clear that the 3-adrenoceptor antagonists 
timolol and carteolol do not mediate an increase in the 
entrapment of spheres in the iris, ciliary body or choroid, 
at a dose of 30nmol. This is a maximal IOP reducing dose in 
this preparation for each of these drugs (Fig.23). Since 
timolol and carteolol exert no effect upon vascular 
perfusion pressure, in the eyes with vascular tone induced, 
it seems likely that neither drug had any effect upon flow 
to the separate parts of the vascular bed. Indeed, it
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appears that the known effects of these drugs upon aqueous 
formation at the doses given in this study are independent 
of any effect upon the state of constriction of the uveal 
blood vessels in this preparation. This is particularly so 
as the tone induced by noradrenaline was submaximal and 
hence likely to be reversible, if timolol or carteolol at 
the given concentration possess any uveal vasodilator 
action.
In the non-noradrenaline perfused group, a more complex 
situation is seen. The reduction in sphere entrapment which 
tirnolol was found to elicit in the choroid at 30nmol bolus 
dose suggests that a maximal IOP reducing dose of tirnolol 
reduces flow to the choroid in the eye with a relaxed 
vasculature. However, the total number of entrapped spheres 
in the non-noradrenaline treated eyes challenged with 30nmol 
timolol did not differ significantly from the numbers in the 
control group, therefore timolol at this dosage had no 
effect upon overall vascular resistance. Timolol (300nmol) 
results in a significant reduction in the numbers of spheres 
entrapped in the iris, and also a statistically 
insignificant reduction in the ciliary body. There is also 
a significant reduction in the overall total numbers of 
spheres entrapped in the ocular vasculature. This suggests 
either that the higher dose of timolol does mediate an 
increase in vascular perfusion pressure, thus reducing flow, 
or alternatively, this dose of timolol mediates a dilatation 
of previously constricted arterio-venous (AV) shunts.
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leading to an increase in the numbers of spheres simply 
passing through the ocular vascular beds and draining from 
the preparation through the venous outflow. However, 
analysis of the small numbers of counts per minute present 
in the effluent and its container indicates that no such 
increase in the numbers of spheres passing directly through 
the eye could be detected. In the case of the group of eyes 
treated with timolol at 300nmol. the significant decrease in 
the total number of spheres entering the ocular circulation 
corresponded with a significant increase in the numbers of 
spheres which failed to enter the eye. This then indicates 
that at a dose which was supramaximal for IOP reduction, 
timolol does mediate vasoconstriction in the iris and 
ciliary body. However, as the perfusate flow rate was 
constant, this dose of timolol should have mediated an 
increase in perfusion pressure. No such increase was seen. 
It may be that the transducer - pen recorder system was 
simply not sensitive enough to register the possibly small 
increase in perfusion pressure in response to timolol at 
this dose.
The results obtained in this study using timolol are 
broadly in agreement with those of Watanabe and Chiou
(1983). who noted a reduction in flow to the choroid in the 
rabbit eye in response to a lh pretreatment with 0.25% 
timolol. However, although these workers also observed a 
reduction in flow to the iris root-ciliary body in response 
to timolol, they reported no change in flow to the iris
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Itself in response to this drug. This contrasts with the 
observation in the present study that at supramaximal 
dosage, a reduction in sphere entrapment and hence 
vasoconstriction occurred in the iris. However, at no point 
was a reduction in sphere entrapment in the ciliary body 
observed in the bovine eye in response to timolol. Why 
there should be a vasoconstriction in the choroid but not 
the iris at a dose which maximally reduced IOP. and the iris 
but not the choroid at supramaximal dose, is unclear. One 
would expect to see such an effect in the choroid at the 
higher dose as well as the lower dose. The failure of 
timolol to mediate a vasoconstriction in the iris at the 
lower dose may be due to the presence of 3-adrenoceptors in 
the vessels of the iris with a lower binding affinity for 
timolol than in the choroid.
Carteolol, 30nmol dose (which yielded maximal ocular 
hypotensive effect) was found to significantly reduce sphere 
entrapment within the iris, ciliary body and choroid in the 
non-noradrenaline perfused group, as compared with saline 
control. This corresponds to a small but significant rise 
in overall perfusion pressure as measured via the transducer 
- pen recorder system. Sphere entrapment proximal to the 
eye in this group was also significantly increased; no 
significant change in the numbers of spheres present in the 
perfusate effluent was found. At constant flow rate, 
therefore, these results are indicative of a significant
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uveal vasoconstriction in response to carteolol, rather than 
to any dilatation of ocular AV shunts.
In comparison with the 300nmol dose of timolol, the 
30nmol dose of carteolol gave rise to a greater reduction in 
the overall number of spheres present in the ocular 
vasculature, and a small but measureable pressure increase 
as recorded via the transducer. This suggests that a 
smaller vasoconstriction in response to timolol may indeed 
have been simply too small for the pressure transducer to 
measure, given its limit of resolution of approx. 0.5 mmHg 
pressure. The results suggest that in the perfused eye 
model, in addition to a reduction in aqueous humour 
formation, both carteolol and timolol may differentially 
affect flow to the various ocular regions. The more 
pronounced uveal pressor responses to carteolol suggest that 
this drug may cause ocular vasoconstriction at doses similar 
to those which lower IOP. This represents a possible 
adverse effect of carteolol. particularly if it promotes 
vasoconstriction in the retinal vessels. These data are in 
conflict with the findings of Baxter et a 1. (1992), using a
technique of Colour Doppler Ultrasound, reported that the 
unilateral instillation of timolol (0.5%) mediated a 
significant fall in the resistive index of the central 
retinal artery and posterior ciliary arteries of both eyes, 
thus probably increasing the blood flow through these 
vessels.
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It has been suggested that the binding of 13- 
adrenoceptors in the ocular vasculature by timolol may lead 
to a reduction in flow via a vasoconstriction as the drug 
may be blocking adrenergically stimulated vasodilation of 
blood vessels (Neufeld. 1979; Neufeld et a 1.. 1983). This 
hypothesis is somewhat weakened by the observation that 
timolol will reduce sphere entrapment in the choroid and 
iris in the isolated perfused eye. which has no intact 
sympathetic innervation. It may be possible, however, that 
even in the isolated eye there may be some release of 
endogenous noradrenaline from intracellular stores, 
promoting a 3-adrenoceptor mediated vasodilation against 
which timolol can act. However, noradrenaline is relatively 
selective for ©C-adrenoceptors, and so even if it is released 
endogenously in this preparation, it would promote 
vasoconstriction (indeed as seen in experimental results 
when noradrenaline is added to the perfusate), rather than 
dilation. The observation that the 3-adrenoceptor 
antagonist carteolol elicits a more pronounced 
vasoconstriction to a greater proportion of the uveal 
circulation than timolol. further weakens this hypothesis, 
as carteolol also possesses intrinsic sympathomimetic 
activity (Koch, 1983). Intrinsic activity at the oc- 
adrenoceptor may account for the vasoconstrictor effect of 
carteolol, however Wilson (1989) found that the 
vasoconstrictor effect of carteolol was not blocked by 
addition of the selective c<i-adrenoceptor antagonist
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phentolamine, thus suggesting that carteolol possesses 
intrinsic activity at the 3-adrenoceptor.
The question of whether a reduction in flow to various 
structures within the eye is responsible for the ocular 
hypotensive action of a drug is further complicated by the 
observations that in the noradrenaline perfused eyes, the 
nitrovasodilator SNP, and the calcium channel antagonist 
verapamil, both elicit an increase in sphere entrapment in 
the iris, ciliary body and choroid. These drugs, in 
addition to mediating a significant increase in ocular 
entrapment, and a reduction in the proximal entrapment, 
caused a large reduction in perfusion pressure. This 
underlines the vasodilator action of these drugs upon the 
uveal vasculature. Both SNP and verapamil have been found 
to lower IOP, at the same dosages as those which mediate 
vasodilation. The picture in the literature is somewhat 
confused. For example, nitrovasodilators have been reported 
to increase IOP in the human eye (Krupin et a 1. . 1977), 
although Karnezis and Murphy (1988) report that i.v. 
infusion of SNP reduces IOP in human volunteers, and Elliott 
et al . (1991) report that topical application of SNP to
hypertensive human volunteers results in a reduction in 
blood pressure, but no change in IOP. In the case of 
calcium channel blockers, Monica et a 1. (1983) and Abelson 
et a 1. (1988) reported a decrease in IOP in human volunteers
in response to topical verapamil. However, Beatty et al.
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(1984) and Kelley & Walley (1988) reported an increase in 
IOP following topical nifedipine in the normal human eye.
Despite the claim of Watanabe and Chiou (1983), a 
reduction in flow to the ciliary body probably does not play 
an important role in the effect of 3-adrenoceptor 
antagonists upon IOP in the perfused eye preparation. 
Dilation or constriction of AV shunts within the uveal 
vasculature in response to the drugs studied in the isolated 
eye preparation probably does not occur, therefore this 
mechanism probably plays no part in the ocular hypotensive 
action of these drugs. Reduction in flow to the choroid or 
iris mediated by these drugs may be involved in their effect 
upon IOP. However the increase in flow to the choroid, 
ciliary body and iris elicited by SNP and verapamil (drugs 
which also reduce IOP in the perfused eye preparation). 
suggests that the drugs studied which lower IOP have direct 
effects upon the secretory ciliary epithelial cells, and 
their varying ability to modify ocular blood flow is 
probably incidental to their ocular hypotensive action.
Such a conclusion is compatible with the work of Bill 
(1975).
Involvement of Ca2+ in Control of IOP
The experimental observations obtained may in part be 
due to the modification of intracellular Ca^+ concentration.
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probably in the non-pigmented ciliary epithelium. 
Intracellular free Ca2+ is known to be important in a great 
many changes in cellular function. Some ion channels are 
known to be Ca2 + dependent (Adams et al.. 1982; Yoshida et 
a l .. 1991; Masao et a 1 . . 1992) and cytosolic free Ca2+ may 
be important in modulating secretion of aqueous. This would 
possibly explain the reported effect of the L-type Ca2+ 
channel antagonists verapamil and nifedipine upon IOP in the 
bovine perfused eye; in each case they reduce intracellular 
free Ca2 + via the blockade of L-type Ca2+ channels, although 
as cited previously there is conflict in the literature 
concerning the ocular effects of these drugs.
The ATP-sensitive K+ channel agonists cromakalim and 
pinacidil. in addition to reportedly mediating a decrease in 
cytosolic free K+ . are also reported as having an effect 
upon cytosolic free Ca2 + (Hamilton & Weston. 1989: Quast & 
Cook. 1989). These workers, investigating various blood 
vessel preparations, reported that cromakalim and pinacidil 
give rise to a hyperpolarization of the cell membrane and 
subsequent closure of voltage-operated Ca2+ channels, 
leading to a decrease in cytosolic free Ca2+ concentration 
and smooth muscle relaxation. Further, it has been noted 
that by the addition of a K+ channel agonist (BRL 38227) 
together with SNP in the guinea-pig internal anal sphincter, 
an enhancement of the relaxation effect produced is seen, as 
compared with the effect of either drug alone (Rae & Muir. 
1992). A similar effect is seen when SNP is added together
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with the Ca^+ channel antagonist diltiazem. A possible 
explanation for this effect is that the presence of the K+ 
channel agonist, or the Ca2+ channel antagonist, promotes 
hyperpolarization of the cell and thus enhances the 
relaxatory effect of SNP. Thus there is the suggestion of a 
further link between cyclic GMP, Ca^+ and K+ in various 
tissues: there may also exist a relationship between these 
intracellular second messengers in the secretory epithelium 
of the ciliary processes.
Agents which promote an increase in intracellular 
cyclic GMP (AP, sodium azide and SNP) may be eliciting a 
concomitant decrease in release of Ca^+ from intracellular 
stores within the ciliary epithelium, as is reported in 
vascular smooth muscle, thus leading once again to a 
reduction in aqueous secretion and hence a reduction in IOP. 
This, however, still begs the question of how a 0- 
adrenoceptor selective antagonist would promote a reduction 
in aqueous secretion, particularly in an isolated eye 
preparation in which there is no intrinsic sympathetic tone 
and hence there should be no agonist effect with which the 
antagonist could compete.
Many ion channels are directly regulated by G proteins 
(Sternweiss & Pang, 1990). oz. and/or 0 subunits of Gj or G0
proteins coupled to the muscarinic acetylcholine receptor 
open an inwardly rectifying K+ channel in cardiac muscle by 
a membrane-delimited pathway (Kurachi et al.. 1992). In 
addition to G protein opening ligand-gated channels, G
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proteins also affect voltage-gated channels. For example,
G0 protein inhibits Ca2+ current in neurones (Scott et a l ..
1991). Recent evidence is consistent with direct opening of 
dihydropyridine-sensitive (L-type) Ca2+ channels by a Gs
protein, without the involvement of a cyclic AMP-dependent
channel phosphorylation (Yatani et a 1., 1987. 1988). The 
same Gs protein that opens L-type Ca2+ channels can also
stimulate adenyl cyclase, however (Yatani et al .. 1988;
Brown & Birnbaumer. 1988). Furthermore, the discovery of &2
adrenoceptors in feline cardiac right-ventricular papillary 
muscle (Lemoine & Kaumann. 1991) which may be positively 
coupled to an L-type Ca2* channel, indicates a possible 
mechanism for the action of 3-adrenoceptor selective 
antagonists upon aqueous secretion, should such receptors 
also exist in bovine ciliary processes. However, Yatani et. 
al. (1988) and Brown and Birnbaumer (1988) suggest that the
concomitant production of cyclic AMP as a result of the 
binding of the receptor by agonist itself promotes 
activation of the cardiac L-type Ca2+ channel, via
phosphorylation of cytosolic protein kinase A (Fig.33), in 
addition to direct activation of the Ca2 + channel by Gs
protein. However, in the isolated perfused eye model, 
agents which directly increase cytosolic cyclic AMP levels 
such as forskolin have no effect upon aqueous secretion rate 
(Shahidullah & Wilson. 1992). Perhaps such receptors may 
exist in the ciliary epithelium coupled to the
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direct G-protein pathway 
Ca2+
phosphorylation pathway
w?m mmi
protein x  
phosphatases ^
isoprenaline
GTP GDP
protein 
kinase A
adenylyl
cyclase
GTP GDP
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ATP
phospho- 
CAMP diesterases* 5' 'AM
Fig.33. Proposed mechanisms of regulation of the voltage-
gated L-type Gaz+ channel in cardiac muscle. Vhen 
isoprenaline binds to the 11-adrenoceptor (dark 
rectangle), nucleotide exchange on the subunit 
of Gs (o^ fly) is accelerated, resulting in activated
Gs°(. GS'X can then activate the Ca^+ channel directly
by binding to (direct G protein pathway) or indirectly 
(phosphorylation pathway) by activating adenyl cyclase 
which synthesises cyclic AMP, which activates cyclic 
AMP-dependent protein kinase (protein kinase A), which
presumably phosphorylates the Ca^+ channel. Cyclic 
AMP may be degraded by a variety of phosphodiesterases
and the Cai_i" channel may be dephosphorylated by one or 
several protein phosphatases (Hartzell & Fischmeister, 
1992) .
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dihydropyridine-sensitive Ca2 + channel directly by Gs
protein only, without being associated with adenyl cyclase. 
The regulation of Ca^+ channels by a Gs protein has
been refuted (Hartzell et al., 1991; Hartzell &
Fischmeister, 1992), however Hartzell et al. base this upon
data obtained from experiments performed upon frog, rat and
guinea-pig cardiac myocytes - in each case a different
species and tissue to the feline cardiac muscle as
investigated by Lemoine and Kaumann (1991). Hartzell &
Fischmeister conclude that although G proteins affect
cardiac Ca2+ channels in lipid bilayers and excised membrane
patches, there is little evidence that this pathway is
physiologically significant. For example, these workers
found that less than 10% of purified L-type Ca2+ channels
would bind to added endogenous G-protein.
There is a possibility that ciliary 32~adrenoceptors
are conf ormat ional ly different from extraocular 132-
adrenoceptors, and will bind both to (-)-timolol and ( + )-
timolol, in both cases yielding antagonism of the receptor,
despite the observations that the (+)-enantiomer of timolol
possesses very limited ability to block 3-adrenoceptors
present at extraocular sites (Share et al ., 1984; Richards &
TattersfieId, 1985. 1987). However, the theory that there 
may be 32~a<irenoceptors positively coupled via a Gs protein
to transmembrane Ca^* channels in the non-pigmented ciliary 
epithelium does not adequately explain all of the 
experimental observations reported to date concerning the
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ocular effects of 3-blocking drugs. If such receptors were 
involved in the control of aqueous secretion then intact 
sympathetic innervation would be required. It would be 
expected that secretion would be reduced in one eye of 
patients with unilateral Horner's syndrome, and that timolol 
would have an effect only upon the unaffected eye. This is 
not in fact the case, however (Wentworth & Brubaker. 1981). 
Additionally, there is still no explanation as to why 
betaxolol possesses similar efficacy to timolol as an ocular 
hypotensive agent, or why the 3-adrenoceptor agonists 
terbutaline (Shahidullah & Wilson, 1992) and isoprenaline 
(Colasanti & Trotter. 1981) reportedly reduce the rate of
aqueous secretion in certain species. Once again, one may 
speculate that perhaps the ciliary 32~adrenoceptor. although 
not selective for most 3i agonists and antagonists, is
conformationa1ly different and has different binding 
characteristics from extraocular 32~adrenoceptors. and will
bind betaxolol. Indeed the topical administration of
betaxolol to rabbits is associated with levels of the drug 
in the aqueous which are capable of blocking 32-
adrenoceptors and this has been suggested as a possible 
mechanism of the ocular hypotensive action of the drug 
(Polansky & Alvarado. 1985).
CONCLUSIONS
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The bovine perfused eye preparation allows for the 
rapid and inexpensive comparative screening of drugs for 
possible ocular hypotensive activity. Additionally, 
comparisons of the effect of a drug upon both IOP and the 
vasculature may be undertaken. Such comparison allows for 
study of the fundamental mechanisms of actions of such 
drugs. The preparation has also proved useful in the more 
sophisticated investigation of the effects of drugs which 
lower IOP upon the vasculature, using a radiolabelled 
microsphere technique. This may be the first time such an 
attempt to assess vascular flow in an isolated perfused 
organ has been made.
The bovine perfused eye offers the opportunity to study 
the effect of ocular hypotensive drugs upon intracellular 
mechanisms, specifically, upon intracellular second 
messenger pathways. The increase in cyclic GMP 
concentration as measured in the ciliary processes in 
response to sodium azide and AP . and measurements of ciliary 
cyclic AMP concentration (Shahidullah & Wilson. 1992) in 
response to terbutaline and forskolin, in association with 
aqueous flow rate determinations, demonstrates the 
usefulness of this preparation for analysis of biochemical 
changes and their relation to aqueous humour dynamics.
Intact adrenergic innervation is not necessary for 
aqueous secretion, nor the reduction in secretion and IOP 
seen in response to ocular hypotensive drugs.
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The ocular hypotensive effect of a number of different 
classes of compound has been successfully demonstrated. The 
ability of the 3-adrenoceptor antagonists to lower IOP in 
this preparation is well established. However, this 
provides evidence opposing the hypothesis that the effect is 
mediated via a conventional 3-adrenoceptor, since this 
occurs in the absence of sympathetic tone. The evidence 
obtained with AP and sodium azide that cyclic GMP may act as 
an important post-receptor mechanism in the ciliary 
epithelium supports the growing body of literature which 
suggests that many cells utilise several of the post­
receptor mechanisms, specifically, cyclic nucleotides, 
inositol phosphates and ion channels. Results obtained with 
sodium azide and AP indicate that their effect on IOP cannot 
be mediated by vasodilation. Data obtained with SNP and 
pinacidil do not exclude the possibility of a causal 
relationship between vasodilation and a reduction in IOP. 
however jthey by no means prove this. Data obtained with 
timolol and carteolol during the microsphere perfusion 
experiments suggest a vasoconstrictive effect of these 
drugs, but only at supramaximal IOP reducing dose in the 
case of timolol. There are also reports in the literature, 
albeit conflicting, of the ocular effects of selected Ca^+ 
channel antagonists: indeed, pilot studies with the present 
preparation indicate a small IOP lowering effect of bolus 
injections of verapamil or nifedipine. Ciliary 
intracellular Ca2+ may play a role in the control of IOP.
FUTURE WORK
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It has been shown that in the bovine perfused eye, 
standard drugs which lower IOP do so by reducing the rate of 
aqueous humour formation, as measured by a fluorescein 
dilution method (Shahidullah & Wilson, 1992). Further work 
with this method should confirm that AP acts by depressing 
aqueous humour formation, as reported by Korenfeld and 
Becker (1989). Similar experiments with the other 
vasodilators used in the present work may indicate that they 
also suppress aqueous secretion. Extending the study of 
cyclic GMP in the ciliary epithelium to examine the effects 
of a range of doses of SNP as well as AP and sodium azide, 
may confirm the hypothesis that all these agents lower IOP 
through their actions on guanylate cyclase.
More precise information concerning the concentration 
of drug actually present at the site of action (probably the 
ciliary epithelium) would be obtained by administering 
ocular hypotensive drugs such as timolol at a fixed 
concentration in the perfusate, rather than as bolus doses.
Investigation of the effects of some other compounds 
upon IOP. such as Ca^ + ionophores. 8-bromo cyclic AMP. 8- 
bromo cyclic GMP and L-NOARG would perhaps provide evidence 
of the mechanisms by which IOP is controlled. Additionally, 
in order to confirm that the ocular hypotensive effect of 
pinacidil is mediated by an ATP-sensitive K+ channel, the 
effect of pinacidil upon IOP could be investigated in the 
presence of perfused glibenclamide, an ATP-sensitive K+ 
channel antagonist. Although aqueous secretion rate has
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been estimated in this model, investigation of drug effects 
upon facility of outflow has yet to be attempted.
Further evidence of the mechanism of action of 3 
blockers in the bovine eye might emerge if eyes were 
perfused with Krebs containing a 32 selective agonist, such
as salbutamol or butoxamine.
A study of the effects upon IOP and vascular relaxation 
of the addition of SNP together with a K+ channel agonist, 
or together with a Ca^+ channel antagonist would perhaps be 
informat ive.
An attempt to culture bovine ciliary epithelial cells
would represent a logical extension of work performed to
date with this preparation. There is of course, the
reservation that during the establishment of a viable cell
culture, the structure of cellular components, including
plasma membrane receptors, often changes. However, there
would be several opportunities offered by this approach.
For example, changes in ciliary intracellular free Ca^+ , 
cyclic AMP. cyclic GMP and IP3 could be determined in
response to incubation with selected drugs. This would 
avoid the potential complication of the presence of ciliary 
stroma and small blood vessels, which may have contaminated 
to some degree the scraped ciliary epithelial cell 
preparations assayed for cyclic GMP in the present work. 
Additionally, since changes in intracellular free Ca^+ are 
involved in the activation of very many cell types, micro­
scale measurements of intracellular free Ca2+, using the
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fura-2 technique (Morgan & Morgan. 1982), could be performed 
upon cell cultures.
By using cell cultures, it is possible to apply 
membrane patching techniques in association with G- 
p r o t e i n / C a 2 +  excision and reinsertion into lipid bilayers. 
Measurements of Ca^+ currents induced by the addition of GTP^ 
S and GTP3S (activator and inhibitor of G-proteins, 
respectively), as reported by Yatani et a 1. (1987) might
then provide further information as to the possible presence 
of G-protein gated Ca- + channels in the ciliary epithelium.
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Appendix I
Statistics
All data is given as: meanis.e.m..
With the exception of the data obtained from the EDRF 
investigation and the radioactive microsphere perfusion 
experiments, all data was analysed using the 2-tailed 
unpaired Student's t-test (Gosset, 1908) of difference 
between population means. Population variances were not 
assumed to be equal.
The test statistic (t) is given by the relation:
(x1-x2)-(ui-U2)
t
where: x = sample mean
u = population mean
s = sample standard deviation
n = sample size
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Degrees of Freedom (df) Is given by the relation of 
Dixon and Massey (1969):
1 2
3l2 s22 
Ln l + n2 .
df =
(s^2/n^) (s92/n0)
n l r>2
Computed values of t were compared with the calculated 
percentiles of the t-distrlbution.
Data obtained from the EDRF investigation was analysed 
using the 2-tailed paired Student's t-test (Gosset, 1908) of 
difference between population means of nonindependent 
samples.
The test statistic (t) is given by the relation:
sd
where: d = mean difference between pretreatment and
post-treatment values of sample 
Ud = mean difference between pretreatment and
post-treatment values of population
196
S& = sample standard error of difference between
pretreatment and post-treatment values of 
sample
Degrees of freedom (df) Is given by the relation:
df = n-1
where: n = sample size
Computed values of t were compared with the calculated 
percentiles of the t-distribution.
Data obtained from the radioactive microsphere 
perfusion experiments was analysed using the 2-tailed Mann- 
Whitney test (Mann & Whitney, 1947) of difference between 
population medians.
The test statistic (T) is given by the relation:
n(n+1)
Where: S = Sum of Ranks assigned to the sample
observations from one population
197
Computed values of T were compared with the calculated 
quantiles of the Mann-Whitney test statistic.
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Appendix II
Materials
Timolol Maleate 
Carteolol Hydrochloride 
Betaxolol Hydrochloride 
Metipranolol 
Metoprolol 
Oxprenolol 
Laevobunolol 
DHL
Sigma Chemical Company 
Sigma Chemical Company 
Sigma Chemical Company 
Sigma Chemical Company 
Sigma Chemical Company 
Sigma Chemical Company 
Strathclyde University 
Strathclyde University
Verapamil Hydrochloride 
Ni fedipine
Cromakalim (BRL 34915) 
Pinacidi1
SNP
Sodium Azide
Acetazolamide 
FPL 65879AA
Sigma Chemical Company 
Sigma Chemical Company
Smith Kline & Beecham 
Sigma Chemical Company
Sigma Chemical Company 
Sigma Chemical Company
Sigma Chemical Company 
Fisons pic
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141Ce-Labe 1 led 15jum Carbonized 
Latex Microspheres
DuPont New England 
Nuclear (NEN)
Cyclic GMP Radioimmunoassay Kit DuPont New England 
Nuclear (NEN)
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The following 
this thesis:
IOP: 
OAG : 
COAG :
ICB: 
SNP : 
DHL: 
Cyclie AMP:
Cyclic GMP:
IP3 :
GTP3S:
GTPa'S:
AP:
ACh:
Appendix III
List of Abbreviations
abbreviations have been used throughout
Intraocular Pressure 
Open-Angle Glaucoma 
Chronic Open-Angle 
Glaucoma
Iris-Ciliary Body 
Sodium Nitroprusside 
Dihydro1aevobuno1o1 
3'5' Cyclic Adenosine 
Monophosphate 
3'5' Cyclic Guanosine 
Monophosphate 
Inositol Trisphosphate
Guanosine Triphosphate 
Beta-S
Guanosine Triphosphate 
Gamma-S
Atriopeptin (Atrial 
Natriuretic Factor) 
Acetylcholine
L-NOARG: 
TCA : 
BSA : 
RIA: 
YAG Laser:
s .e.m:
ram: 
m m H 2 0 :
mmHg:
i . V:
°C: 
M: 
h: 
m i n : 
s :
g:
m g : 
ug: 
ml :
wl :
mol :
jumol :
nmol : 
pmo 1 :
L-Nitroarginine
Trichloroacetic Acid
Bovine Serum Albumin
Radioimmunoassay
Nitrogen Yttrium-Argon-
Garnet Laser
Standard Error of Mean
Mi 11imetres 
Millimetres of Water
Millimetres of Mercury
Intravenous
Degrees Celcius
Molar
Hours
Minutes
Seconds
Grammes
Mi 11igrammes
Microgrammes
Mi 11 i1itres
Microlitres
Moles
Micromoles
Nanomoles 
Picomoles
